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ABSTRACT 
 Skeletal muscle (SM) mitochondria generate the majority of adenosine 
triphosphate (ATP) in SM, and help regulate whole-body energy expenditure. Obesity is 
associated with alterations in SM mitochondria, which are unique with respect to their 
arrangement within cells; some mitochondria are located directly beneath the sarcolemma 
(i.e., subsarcolemmal (SS) mitochondria), while other are nested between the myofibrils 
(i.e., intermyofibrillar (IMF) mitochondria). Functional and proteome differences specific 
to SS versus IMF mitochondria in obese individuals may contribute to reduced capacity 
for muscle ATP production seen in obesity. The overall goals of this work were to (1) 
isolate functional muscle SS and IMF mitochondria from lean and obese individuals, (2) 
assess enzyme activities associated with the electron transport chain and ATP production, 
(3) determine if elevated plasma amino acids enhance SS and IMF mitochondrial 
respiration and ATP production rates in SM of obese humans, and (4) determine 
differences in mitochondrial proteome regulating energy metabolism and key biological 
processes associated with SS and IMF mitochondria between lean and obese humans. 
 Polarography was used to determine functional differences in isolated SS and 
IMF mitochondria between lean (37 ± 3 yrs; n = 10) and obese (35 ± 3 yrs; n = 11) 
subjects during either saline (control) or amino acid (AA) infusions. AA infusion 
increased ADP-stimulated respiration (i.e., coupled respiration), non-ADP stimulated 
respiration (i.e., uncoupled respiration), and ATP production rates in SS, but not IMF 
mitochondria in lean (n = 10; P < 0.05). Neither infusion increased any of the above 
parameters in muscle SS or IMF mitochondria of the obese subjects. 
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 Using label free quantitative mass spectrometry, we determined differences in 
proteomes of SM SS and IMF mitochondria between lean (33 ± 3 yrs; n = 16) and obese 
(32 ± 3 yrs; n = 17) subjects. Differentially-expressed mitochondrial proteins in SS versus 
IMF mitochondria of obese subjects were associated with biological processes that 
regulate: electron transport chain (P<0.0001), citric acid cycle (P<0.0001), oxidative 
phosphorylation (P<0.001), branched-chain amino acid degradation, (P<0.0001), and 
fatty acid degradation (P<0.001). Overall, these findings show that obesity is associated 
with redistribution of key biological processes within the mitochondrial reticulum 
responsible for regulating energy metabolism in human skeletal muscle.
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CHAPTER 1: INTRODUCTION 
 Obesity results from an energy surplus and is characterized by an accumulation of 
excess body fat. Incidence of obesity has increased in the United States where the age-
adjusted prevalence of obesity in 2013-2014 was 35.0% among men and 40.4% among 
women  (Flegal, Kruszon-Moran, Carroll, Fryar, & Ogden, 2016). A key biological 
process associated with obesity is a reduced capacity of ATP production in skeletal 
muscle (Abdul-Ghani et al., 2009). The reduced capacity of ATP production in skeletal 
muscle mitochondria from obese has been associated with the term mitochondrial 
dysfunction (Hojlund et al., 2010; Hwang et al., 2010; Karakelides et al., 2010; Koves et 
al., 2008; Menshikova et al., 2005; Minet & Gaster, 2010; Ritov et al., 2005; Toledo et 
al., 2008). In turn, defining mitochondrial dysfunction has been difficult. Conflicting 
reports suggest skeletal muscle mitochondria from obese individuals have a reduced 
ability to oxidize fatty acids (Koves et al., 2008; Razak & Anand, 2004). Consequently 
this has been suggested to lead to lipid accumulation within skeletal muscle (Adams et 
al., 2004; Boyle, Zheng, Anderson, Neufer, & Houmard, 2012; Koves et al., 2008). 
Alternatively, skeletal muscle mitochondria from obese individuals have been reported as 
comparable to lean controls (Fisher-Wellman et al., 2014; Holloway et al., 2007). 
Normally, skeletal muscle mitochondria generate more than 90% of the available 
adenosine triphosphate (ATP) in skeletal muscle, which helps to regulate whole body 
energy metabolism. In addition, skeletal muscle, one of the primary tissues for regulating 
whole-body energy metabolism, contains one of the largest collections of proteins in the 
body (Chevalier, Marliss, Morais, Lamarche, & Gougeon, 2005; Wolfe, 2006). 
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Maintenance of the skeletal muscle mitochondrial protein pool is important to the overall 
function of myocytes and muscle metabolic health. 
 Healthy mitochondrial proteins support the maintenance of energy metabolism 
through the generation of ATP. Previous studies have shown differences in skeletal 
muscle mitochondria from obese individuals with respect to size and abundance (Kelley, 
He, Menshikova, & Ritov, 2002; Ritov et al., 2005). Consequently, the reduced size and 
abundance of mitochondria from muscle of obese individuals, might predict a reduced 
capacity, along with lower rates, of ATP production in obesity (Abdul-Ghani et al., 2009; 
Chanseaume et al., 2010). In turn, lower rates of ATP production in skeletal muscle of 
obese individuals may lead to early fatigability during exercise resulting in reduced levels 
of activity (Cooper, Page, Fox, & Misson, 2000; Ravussin et al., 1988).  Lower activity in 
obese individuals leads to a reduced daily expenditure of energy and ultimately an energy 
surplus (Ravussin et al., 1988) when caloric intake is maintained.  
 Expected medical care costs associated with obesity treatment are rising annually 
(Finkelstein, Trogdon, Cohen, & Dietz, 2009; Jacob, 2015) Additionally, risks of 
diabetes, heart disease, and cancer are linked to obesity (Hossain et al., 2016; Ritov et al., 
2005; Sverdlov et al., 2014). The financial burden on the healthcare system to treat 
obesity continues to rise as access to food increases in parallel with the adoption of a 
more sedentary lifestyle. Furthermore, there is no evidence of a decline in the prevalence 
of obesity in any age groups, despite substantial efforts to target the issue (Skinner, 
Perrin, & Skelton, 2016).  
 Practical treatments for obesity include nutritional and exercise interventions. 
Lifestyle interventions to treat obesity such as nutrition, specifically the increased intake 
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of protein/amino acids, and exercise have been shown to effect skeletal muscle 
mitochondrial function (Guillet et al., 2009; Tatpati et al., 2010). Furthermore, increased 
availability of amino acids has also been shown to promote protein synthesis in skeletal 
muscle at the total (Bohé, Low, Wolfe, & Rennie, 2003; Guillet et al., 2009; Katsanos, 
Kobayashi, Sheffield-Moore, Aarsland, & Wolfe, 2005, 2006; Volpi, Kobayashi, 
Sheffield-Moore, Mittendorfer, & Wolfe, 2003) as well as mitochondrial protein levels 
(Guillet et al., 2009; Tatpati et al., 2010), which results in higher skeletal muscle 
mitochondrial ATP production (Tatpati et al., 2010). 
 A growing body of evidence has revealed that skeletal muscle mitochondria are 
arranged in a reticulum within the muscle fiber (Amchenkova, Bakeeva, Chentsov, 
Skulachev, & Zorov, 1988; Bakeeva, Chentsov YuS, & Skulachev, 1978; Dirksen, 2009; 
Glancy et al., 2015, 2017; Kirkwood, Munn, & Brooks, 1986; Ogata & Yamasaki, 1997; 
Patel, Glancy, & Balaban, 2016). This unique arrangement has been suggested to 
facilitate the transmission of energy from the periphery of the muscle fiber to the interior 
regions (Amchenkova et al., 1988; Glancy et al., 2015, 2017; Skulachev, 2001). Cellular 
mitochondrial networks permit the sharing of metabolites, proteins as well as 
mitochondrial deoxyribose nucleic acid (DNA) (Bach et al., 2003; Elachouri et al., 2011). 
The mitochondrial reticulum also provides the architecture to facilitate the rapid 
conductive path for the distribution of potential energy (Glancy et al., 2015). This 
conductive pathway is the major mechanism (Glancy et al., 2015; Patel, Glancy, & 
Balaban, 2016) in skeletal muscle under normal conditions, and the facilitated diffusion 
of metabolites becomes significant as maximum performance levels are approached 
(Glancy et al., 2015). Therefore, it is possible that proteins and metabolites associated 
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with energy metabolism in skeletal muscle during obesity is disrupted, reorganized or 
redistributed in such a way as to match the energy demands of the myocyte mitochondrial 
reticulum network.  
 The biochemically distinct subpopulations of skeletal muscle mitochondria 
localize in the periphery of the cell directly beneath the sarcolemma, historically termed 
subsarcolemmal (SS) mitochondria or are nested in between the myofibrils, 
intermyofibrillar (IMF) mitochondria (Palmer, Tandler, & Hoppel, 1977). Palmer et al. 
were one of the first to demonstrate that these two populations of mitochondria could be 
independently isolated from muscle fibers (Palmer et al., 1977; Palmer, Tandler, & 
Hoppel, 1985). However, the isolation of IMF mitochondria from skeletal muscle 
requires the addition of protease to liberate the mitochondria tethered to myofibrillar 
elements (Idell-Wenger, Grotyohann, & Neely, 1982; Palmer, Tandler, & Hoppel, 1977; 
Thakar & Ashmore, 1975). 
 Using the protease Nagarse to isolate mitochondria significantly improves indices 
of functional integrity and specific activities of isolated mitochondria from skeletal 
muscle (Kras et al., 2016). Studies from chapter 3 and 4 emphasize the differences in SS 
and IMF mitochondria between lean and obese; due to this confounding factor when 
isolating SS and IMF mitochondria from muscle from lean and obese individuals, the 
mitochondrial subpopulations are compared independent of one another in those studies. 
However, the ability to independently study distinct regional fractions of skeletal muscle 
mitochondrial reticulum, i.e. SS and IMF mitochondria, may provide insight into the 
proteome, function and mechanisms, which contribute to changes in energy metabolism 
of skeletal muscle mitochondria in obese. 
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 Previously reported differences in skeletal muscle mitochondrial ATP production 
observed in muscle from obese (Abdul-Ghani et al., 2009) could be specific to the 
regions of biochemically distinct skeletal muscle mitochondria studied. Furthermore the 
SS mitochondria are more responsive to metabolic changes, compared to IMF 
mitochondria (Bizeau, Willis, & Hazel, 1998; Chomentowski, Coen, Radiková, 
Goodpaster, & Toledo, 2011; Cogswell, Stevens, & Hood, 1993; Crescenzo et al., 2006; 
Koves et al., 2005). Consequently, metabolic changes associated with obesity may 
particularly affect the SS mitochondria.  
 There are reported differences in the proteome of skeletal muscle mitochondria 
from obese individuals (Hojlund et al., 2010; Højlund et al., 2003; Hwang et al., 2010; 
Lefort et al., 2010), which may contribute to a reduced capacity of ATP production in 
muscle from obese (Abdul-Ghani et al., 2009). Earlier studies have observed significant 
increases in the abundance of adenylate kinase (KAD2), an enzyme which catalyzes the 
near equilibrium interconversion of two molecules of adenosine diphosphate (ADP) to an 
ATP and an adenosine monophosphate (AMP); a key enzyme in maintenance of 
intracellular adenine nucleotide ratios (Hittel, Hathout, Hoffman, & Houmard, 2005). In 
this same study, they concluded that reduced mitochondrial content and function with 
increasing obesity, would lower the total cellular ATP yield. This in turn would 
necessitate the need to increase the abundance of adenylate kinase and other glycolytic 
enzymes; helping to maintain intracellular free energy of ATP (Hittel et al., 2005). The 
reorganization of muscle enzymes during specific physiologic conditions, (i.e. exercise 
and fasted states) is well established in the literature (Bizeau et al., 1998; Leek, Mudaliar, 
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Henry, Mathieu-Costello, & Richardson, 2001; Saleem & Hood, 2013; Smith et al., 2013; 
Wibom et al., 1992). 
 Differences in the skeletal muscle mitochondrial proteome of obese have also 
revealed changes in the enzymes responsible for the catalysis of ADP phosphorylation, 
specifically the beta-F1-ATPase subunit. This critical enzyme is reported as lower in 
muscle from obese individuals (Tran et al., 2016). Furthermore, previous groups have 
shown that beta-F1-ATPase is altered in obesity (Hojlund et al., 2010; Hwang et al., 
2010). The changes in skeletal muscle in obesity are also associated with differences in 
rates of protein synthesis (Guillet et al., 2009; Tran et al., 2016). The impairments of 
protein synthesis and mitochondrial ATP production observed in muscle from obese 
individuals could be specific to the population of skeletal muscle mitochondria studied. 
As a result, SS mitochondria in the periphery of the myocyte may be particularly tailored 
for the generation of the proton-motive force (PMF), while IMF mitochondria, proximal 
to myofibrils, effectively utilizes the PMF to generate ATP. This concept agrees with the 
model suggested by Skulachev (Bakeeva et al., 1978) and recently supported by Glancy 
et al. (Glancy et al., 2015). Others have also demonstrated that obese subjects show 
blunted insulin stimulated mitochondrial protein turnover and breakdown compared to 
lean controls (Guillet et al., 2009), further supporting the idea of a disruption in the 
mitochondrial protein turnover, and possibly abundance, within skeletal muscle of obese 
individuals. The exact mechanisms responsible for the reduced capacity of ATP 
production in response to increased availability of energy such as amino acids, in skeletal 
muscle from obese individuals are still unknown. 
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 Therefore the goal of this dissertation was to: (1) better understand differences in 
the function of isolated skeletal muscle mitochondria; (2) determine the effects in 
mitochondrial function in response to the stimulatory effect of plasma amino acids; (3) 
determine differences in the proteomes of muscle mitochondria from lean versus obese 
humans; and (4) identify key differences with respect to biological processes associated 
with the regulation of energy metabolism in both subsarcolemmal and intermyofibrillar 
mitochondria between healthy lean and healthy obese individuals. The work included 
herein involves the functional assessment of isolated SS and IMF mitochondria from 
skeletal muscle between healthy lean and apparently healthy obese individuals, and the 
underlying mechanisms responsible for the reduced capacity of skeletal muscle 
mitochondrial ATP production from obese individuals. Therefore, to better understand 
the differences in the function and proteome of SS and IMF mitochondria in skeletal 
muscle of obese individuals, I have investigated the following: (1) total and specific 
activity of enzymes associated with regulating energy metabolism; (2) the capacity of 
ATP production under basal conditions and during a stimulus such as amino acids; and 
(3) differences in the proteomes of SS and IMF mitochondria between lean and obese 
humans. Assessment of SS and IMF mitochondrial function was carried out by oxygen 
consumption assays using oxygen electrode polarography, while identification and 
quantification of differentially expressed proteins in SS and IMF mitochondrial assigned 
proteins was carried out using label free quantitative mass spectrometry and total spectra 
counts between relatively healthy lean and obese participants. 
 Overall, the work in this dissertation revealed the following with respect to 
differences in SS and IMF mitochondria between lean and obese individuals: as expected, 
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the function of SS and IMF mitochondria were not different between lean and obese at 
basal when subjects were matched for age and physical activity; our results further 
described that SS (but not IMF) mitochondria were stimulated by amino acids and 
surprisingly, enhanced uncoupled respiration while sustaining increased capacity for ATP 
production from lean subjects only; none of these effects of plasma amino acids were 
observed in IMF mitochondria of either lean or obese subjects. In alignment with 
expectations, quantitative proteomics revealed that the total abundance of mitochondrial 
assigned proteins in both SS and IMF mitochondria were reduced in obese individuals, 
but unexpectedly, the reduced abundance of total spectra in SS mitochondria from obese 
individuals could not be attributed to mitochondrial proteins assigned to the citric acid 
cycle, electron transport chain or ATP synthase. Further investigation revealed that the 
reduced abundance of spectra in SS mitochondria of obese was primarily the result of a 
lower total abundance of spectra assigned to proteins involved in the metabolism of 
proteins. Unlike SS mitochondria, the abundance of mitochondrial proteins assigned to 
electron transport chain and ATP synthase were reduced, while proteins from the citric 
acid cycle and succinate-coenzyme Q reductase (i.e. complex II) were increased in IMF 
mitochondria of obese subjects. Collectively, this dissertation provides novel findings in 
obesity with respect to the function and distribution of protein composition in myocytes 
related to regulating energy metabolism in obese humans. 
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CHAPTER 2: SUBSARCOLEMMAL MITOCHONDRIA ISOLATED WITH THE 
PROTEOLYTIC ENZYME NAGARSE EXHIBIT GREATER PROTEIN SPECIFIC 
ACTIVITIES AND FUNCTIONAL COUPLING 
Katon A. Kras, Wayne T. Willis, Natalie Barker, Traci Czyzyk, Paul R. Langlais, 
Christos S. Katsanos 
 
Abstract 
 Skeletal muscle mitochondria are arranged as a reticulum. Insight into the 
functional characteristics of such structure is achieved by viewing the network as 
consisting of “subsarcolemmal” (SS) and “inter-myofibrillar” (IMF) regions. During the 
decades, most, but not all, published studies have reported higher (sometimes over 2-
fold) enzyme and enzyme-pathway protein-specific activities in IMF compared to SS 
mitochondria. We tested the hypothesis that non-mitochondrial protein contamination 
might account for much of the apparently lower specific activities of isolated SS 
mitochondria. Mouse gastrocnemii (n=6) were suspended in isolation medium, minced, 
and homogenized according to procedures typically used to isolate SS mitochondria. 
However, the supernatant fraction, collected after the first slow-speed (800g) 
centrifugation, was divided equally: one sample was exposed to nagarse (MITO+), while 
the other was not (MITO-). Nagarse treatment reduced total protein yield by 25%, while 
it increased protein-specific respiration rates (nmol O2 min-1 mg-1), by 38% under 
“resting” (state 4) and by 84% under maximal (state 3) conditions. Nagarse therefore 
increased the respiratory control ratio (state 3/state 4) by 30%. In addition, the ADP/O 
ratio was increased by 9% and the activity of citrate synthase (U/mg) was 49% higher. 
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Mass spectrometry analysis indicated that the MITO+ preparation contained less 
contamination from non-mitochondrial proteins. We conclude that nagarse treatment of 
SS mitochondria removes not only non-mitochondrial proteins but also the protein of 
damaged mitochondria, improves indices of functional integrity, and the resulting 
protein-specific activities. 
Introduction 
 Mitochondrial oxidative phosphorylation fulfills two critical metabolic objectives: 
1) synthesizing ATP at the rate demanded by cellular ATP-utilizing processes and 2) 
maintaining a robust cellular energy status (low cytosolic [ADP] and high ATP/ADP 
ratio). Almost 40 years ago Skulachev's laboratory provided evidence that mitochondria 
in mammalian striated muscle are structured as a continuous network or reticulum 
(Bakeeva, Chentsov YuS, & Skulachev, 1978). Recently, Glancy et al. (Glancy et al., 
2015) provided compelling corroborative evidence for this model. Further, their report 
supports one of the fundamental hypotheses advanced by Skulachev over 40 years ago 
(Bakeeva et al., 1978), that the reticular arrangement provides the ability to rapidly 
transfer intracellular energy by propagating the proton-motive-force (Δp) from one region 
of the network to another (Amchenkova, Bakeeva, Chentsov, Skulachev, & Zorov, 1988; 
Bakeeva et al., 1978; Skulachev, 2001). According to this concept, the fraction of the 
network located near the plasma membrane (“subsarcolemmal” or SS mitochondria) 
contains protein stoichiometry particularly suited for Δp development, while the region 
deeper within the myocyte, the intermyofibrillar (IMF) fraction, is particularly tailored 
for transducing Δp into ATP synthesis and export. Reticular structure therefore facilitates 
meeting the demands for both rapid ATP turnover and the defense of cellular energetic 
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status. These older and more recent findings bracket decades of research supporting the 
mitochondrial reticulum concept. About the time Skulachev's paper demonstrated the 
mitochondrial reticulum in rat diaphragm (Bakeeva et al., 1978), Palmer et al. described 
procedures for independently isolating SS and IMF mitochondrial populations from rat 
heart (Palmer, Tandler, & Hoppel, 1977). Briefly, the tissue was minced, suspended in 
buffer, mechanically disrupted (liberating SS mitochondria) and centrifuged at slow 
speed, leaving SS mitochondria in the supernatant, while the IMF mitochondria were 
pelleted with the myofibrils. This first supernatant was then used to isolate SS 
mitochondria with high-speed spins. In the parallel IMF isolation procedure, the 
myofibrillar pellet was resuspended and incubated with the proteolytic enzyme nagarse to 
digest myofibrillar proteins and liberate the IMF mitochondria. Next, a second slow spin 
would yield a supernatant containing IMF mitochondria. The IMF supernatant was then 
centrifuged at high speed to pellet and wash the IMF mitochondria. These careful and 
detailed studies by Palmer et al. (Palmer et al., 1977; Palmer, Tandler, & Hoppel, 1985) 
provided convincing electron microscopic evidence that SS and IMF fractions were 
independently isolated, and their procedures became the generally accepted methodology 
upon which subsequent work was based. However, a curious pattern reported by Palmer 
et al., and many studies that followed (Bizeau, Willis, & Hazel, 1998; Cogswell, Stevens, 
& Hood, 1993; Palmer et al., 1977, 1985; Schwerzmann, Hoppeler, Kayar, & Weibel, 
1989; Takahashi & Hood, 1993), was that essentially all activities of individual enzymes 
and/or oxidative enzyme pathways were uniformly higher in the IMF fraction compared 
to the SS, in some cases over 2-fold higher. This consistent finding raises obvious 
questions: If SS and IMF mitochondria are simply part of a continuous network, then 
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how could all protein-specific activities be higher in IMF? Another, related, question is: 
where and by what mechanism would the network transition from this SS (lower) to IMF 
(higher) protein-specific activity? One obvious alternative explanation is that these 
apparent differences simply reflect experimental artifact. SS mitochondria are isolated in 
the absence of nagarse exposure, while IMF isolation fundamentally depends on the 
nagarse incubation. Because nagarse treatment is the glaring difference between the two 
procedures, we tested the simple hypothesis that non-mitochondrial protein 
contamination accounts for the apparently lower specific activities of isolated SS 
mitochondria. Our data support this hypothesis and moreover advance the concept that 
nagarse treatment may also remove the protein within and perhaps also attached to 
damaged mitochondria that, left undigested, would otherwise diminish indices of 
mitochondrial structural and functional integrity. 
Methods 
Animal and muscle preparation  
 All procedures were in accordance with the guidelines regarding the care and use 
of animals by the Institutional Animal Care and Use Committee at Mayo Clinic. A total 
of six C57BL/6 J mice on standard chow diet and water ad libitum were used for all 
experiments. Mice ranged in age from 8 to 12 weeks. On the day of the experiment, the 
mice were euthanized by isoflourane inhalation and cervical dislocation. The left and 
right gastrocnemii were removed and immediately placed on an ice-cold petri dish, which 
was pre-rinsed with ice-cold modified Chappell-Perry Medium I (Solution I; mM): 100 
KCl, 40 Tris–HCl, 10 Tris-Base, 5 MgCl2, 1 EDTA, 1 ATP, pH 7.5. After removing the 
blood, fat and visible connective tissues, the gastrocnemii were placed into a pre-massed 
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beaker containing 2ml of ice-cold Solution I, reweighed, and the wet muscle mass was 
calculated. The mean gastrocnemii mass was 138.7±10.5 mg.  
Isolation of mitochondria  
 Mitochondria were prepared according to the outline in Figure 2-1; all procedures 
were carried out on ice or at 4 °C and all centrifugations were 10 min in duration. 
Muscles were cleaned, weighed, minced with scissors in 9 volumes of ice-cold Solution I, 
and gently homogenized by hand using a ground glass-to-glass Potter-Elvehjem 
homogenizer (5 passes). The homogenate was centrifuged at 800g to obtain the 
supernatant (SN) containing mechanically released (SS) mitochondria. This SN was 
divided equally into two 1.5 ml homogenization tubes. Nagarse (bacterial proteinase 
Type XXIV, Sigma, P-8038) was prepared using Solution I (5mg g-1 ww) and added to 
one tube (SN+). An equal volume of Solution I containing no nagarse, was added to the 
other tube (SN-). After 7 min incubation, 1ml of Solution I was added to each tube (this 
terminated nagarse digestion in the SN+ tube). The SN+ and SN- samples were then 
centrifuged at 14,000g to obtain two mitochondrial pellets, one exposed to nagarse 
(MITO+) and the other not exposed (MITO-). After discarding the supernatant, each of 
the mitochondrial pellets were re-suspended in 0.5 ml of Solution II (mM): 100 KCl, 40 
Tris–HCl, 10 Tris–Base, 5 MgCl2, 1 EDTA, 0.2 ATP, and 1.5% BSA, pH 7.5. Following 
centrifugation at 7000g, the supernatants were discarded and the mitochondrial pellets 
were re-suspended in 0.5 ml of Solution III (identical to Solution II, but without BSA). 
After the final centrifugation at 4000g and removal of supernatant, the two final 
mitochondrial pellets were each re-suspended in identical volumes of mannitol-sucrose 
buffer containing (mM) 220 Mannitol, 70 Sucrose, 10 Tris–HCl, 1 EGTA, pH 7.40. The 
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volume of buffer used to resuspend each mitochondrial preparation was 1 µl per mg of 
original wet muscle. The protein content in the final mitochondrial preparations was 
determined by the method of Lowry (Lowry, Rosebrough, Farr, & Randall, 1951). All 
protein concentrations reported below and in the Tables relate exclusively to the final 
mitochondrial preparations. 
	 22 
 
 
Figure 2-1. Isolation and treatment of the muscle mitochondria. A flow diagram is shown 
depicting the preparation of mechanically released mitochondrial sample that was 
subsequently either exposed or not to the enzyme nagarse. Details are given in the 
“Methods” (SN, supernatant).
	 23 
Citrate synthase assay  
 Citrate synthase (CS) activity was determined spectrophotometrically at 37 °C by 
the method of Srere (Srere, 1969), as previously described (Lefort et al., 2010). In these 
assays aliquots of mitochondrial suspensions, stored at -80 °C, were assayed in buffer 
that included 0.05% Triton detergent to disperse the mitochondrial inner membrane and 
eliminate all enzyme latency.  
Assays for mitochondrial O2 consumption and ATP production  
 Freshly isolated mitochondria were assayed for O2 consumption rate (Jo) and 
ATP production rate (Jp). O2 consumption was measured polarographically in a 
respiration chamber (Hansatech Instruments, Norfolk, UK) at 37 °C following general 
procedures we have previously described (Lefort et al., 2010). Mitochondrial respiration 
was fueled with the substrate combination pyruvate (1 mM)+malate (1 mM)+glutamate 
(10 mM) (PMG). Aliquots, typically 20 µl in volume, of mitochondrial suspension were 
added to 250 µl of respiration medium adapted from Wanders et al. (Wanders, Groen, 
Van Roermund, & Tager, 1984), which contained (in mM) 100 KCl, 50 MOPS, 10 
K2PO4, 10 MgCl2, 1 EGTA, and 0.2% BSA, pH 7.00 (Lefort et al., 2010). Next, the 
PMG substrate combination was added and State 2 Jo was followed (respiration due 
primarily to proton leak). The addition of ADP to give a final concentration of 0.67 mM 
stimulated state 3, (maximal) Jo. Phosphorylation of this ADP resulted in state 4 Jo 
(Estabrook, 1967), and the respiratory control ratio (RCR) was calculated as state 3 
Jo/state 4 Jo. The ADP/O ratio was determined as previously described (Estabrook, 
1967). The State 3 (maximal) rate of ATP production was calculated as the product of 
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state 3 Jo times the ADP/O (taking the 2:1 molecular to atomic oxygen stoichiometry into 
account).  
Protein separation by SDS-PAGE 
 Final MITO+ and MITO- suspensions were diluted 1:1 in 2 x Laemmli sample 
buffer before running on a SDS-PAGE gel. Laemmli sample buffer containing β-
mercaptoethanol was prepared according to manufacturer's instructions (Bio-Rad, 
Hercules, CA). Samples were heated at 95 °C for 5 minutes and then loaded onto a pre-
cast 10% SDS-PAGE gel (Bio-Rad, Hercules, CA). The gel was run at 60 V for 30 
minutes, 110 V for 60 minutes and then 150 V for 10 minutes. Performing gel 
electrophoresis under these conditions allowed for adequate separation, visualization, and 
the ability to compare the MITO+ versus MITO- samples. Proteins were visualized using 
Coomassie blue. Gel image was captured using an ImageQuant LAS 4000 (GE 
Healthcare Life Sciences).  
Protein identification and quantification by mass spectrometry  
 To obtain an insight into the abundance of mitochondrial versus non-
mitochondrial proteins contained in each of the MITO+ and MITO- preparations, aliquots 
from the samples analyzed on SDS-PAGE were also analyzed by mass spectrometry to 
identify and quantify proteins contained in each mitochondrial preparation. The mass 
spectrometry procedure was also used to identify and quantify the protein nagarse in the 
same preparations.  
In-solution digest  
 A volume of isolated mitochondrial preparation, either treated or not treated with 
the enzyme nagarse, was added to a 9 times volume of dilution buffer [DB - 10% 
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acetonitrile (ACN) and 25mM Tris-HCl pH 8.5]. 8 µl trypsin (Sigma; St. Louis, MO) at 
0.200 µg/ml was added to the protein sample and was allowed to incubate for 16 h at 
37°C with gentle shaking, followed by addition of 50 µl 5% formic acid (FA) to halt the 
digestion. The resulting peptides were prepared for sample analysis similar to a 
previously published protocol (Kulak, Pichler, Paron, Nagaraj, & Mann, 2014). In brief, a 
stop-and-go extraction tip (StageTip) (Rappsilber, Mann, & Ishihama, 2007), was fitted 
with two C18 disk plugs using a customized tipping syringe (Rappsilber et al., 2007). The 
Stage Tip was activated with methanol, washed in 100 µl buffer B (0.1% FA, 80% ACN), 
and equilibrated in 100 µl buffer A (0.1% FA) twice. The peptides were then loaded onto 
the activated Stage Tip, washed twice in 100 µl buffer A, followed by elution in 50 µl 
Buffer B. The eluate was dried by vacuum centrifugation and stored at -80 °C prior to 
use. 6 µl of 0.1% FA (v/v) was added to re-suspend the dried samples, followed by 
sonication for 2 min. The sonicated samples were briefly centrifuged and 1 µl of sample 
was subsequently analyzed by mass spectrometry as described below.  
Mass spectrometry  
 HPLC-ESI-MS/MSn was performed on a Thermo Electron Orbitrap Elite Velos 
Pro fitted with an EASY source (Thermo Electron, San Jose, CA). NanoLC was 
performed using a DIONEX/Thermo NCS-3500RS UltiMate 3000 with an EASY Spray 
column (Thermo Electron, 50 cm x 75-µm inner diameter, packed with PepMap RSLC 
C18 material, 2 µm); loading phase for 15 min; mobile phase, linear gradient of 1–37% 
ACN in 0.1% FA in 150 min, followed by a step to 95% ACN in 0.1% FA over 5 min, 
hold 10 min, and then a step to 1% ACN in 0.1% FA over 1 min and a final hold for 19 
min (total run 200 min); Buffer A=0.1% FA in 100% H2O; Buffer B=0.1% FA in 100% 
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ACN; flow rate, 300 nl/min. All solvents were mass spectrometry grade. A “top 15″ data-
dependent MS/MS analysis was performed (acquisition of a full scan spectrum followed 
by collision-induced dissociation mass spectra of the 15 most abundant ions in the survey 
scan).  
Database search  
 Tandem mass spectra were extracted by ProteoWizard msConvert, version 3 
(Chambers et al., 2012) using the default settings. Charge state deconvolution and 
deisotoping were not performed. All MS/MS spectra were analyzed using Mascot (Matrix 
Science, London, UK; version 2.4.1). Mascot was set up to search the 
SwissProt_02_2015 database (16,706 entries, mus musculus) assuming the digestion 
enzyme trypsin and a maximum of 2 missed cleavages permitted. Mascot searched with a 
fragment ion mass tolerance of 0.50 Da and a parent ion tolerance of 10.0 PPM. 
Phosphorylation of serine, threonine, and tyrosine as well as oxidation of methionine was 
specified in Mascot as a variable modification while no fixe modifications were 
indicated.  
Criteria for protein identification  
 Scaffold (version Scaffold_4.3.4, Proteome Software Inc., Portland, OR) was 
used to validate MS/MS based peptide and protein identifications. Peptide identifications 
were accepted if they could be established at greater than 95.0% probability. Peptide 
Probabilities were assigned by the Peptide Prophet algorithm (Keller, Nesvizhskii, 
Kolker, & Aebersold, 2002) with Scaffold delta-mass correction as well as by the 
Scaffold Local FDR algorithm. Protein identifications were accepted if they could be 
established at greater than 99.0% probability and contained at least 2 identified peptides. 
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Protein probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii, Keller, 
Kolker, & Aebersold, 2003). Proteins that contained similar peptides and could not be 
differentiated based on MS/MS analysis alone were grouped to satisfy the principles of 
parsimony.  
Quantification of mitochondrial and non-mitochondrial proteins  
 Progenesis software (Nonlinear Dynamics; Progenesis QI; Quayside, Newcastle 
Upon Tyne, UK) was used to quantify abundance of peptides associated with each 
protein. Quantification using non-conflicting peptides was selected to generate the 
protein report for the peptide ion abundance associated with each identified protein. 
Accession numbers were imported into SwissProt_02_2015 database and used to assign 
the subcellular location of the identified proteins (i.e. mitochondrial, non-mitochondrial). 
Peptide ion abundances for all mitochondrial and all non- mitochondrial proteins in each 
of the MITO+ and MITO- samples were added to calculate total mitochondrial and total 
non-mitochondrial protein abundances, respectively.  
Quantification of the nagarse abundance  
 To quantify the abundance of nagarse present in the mitochondrial preparations 
treated/not treated with nagarse, we used the same approach described in the “Database 
search,” section, but with the following exception: Mascot was set up to search the 
SwissProt_02_2015 database for bacillus licheniformis. We used the unique and stable 
identifier from the SwissProt_02_2015 database for nagarse, Q65LP7, to perform all 
queries. We also used the corresponding mnemonic identifier of the UniprotKB entry, 
Q65LP7_BACLD to perform all protein queries. The ion abundance for the peptides 
associated with the enzyme nagarse within each of the mitochondrial preparations were 
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compared with the total ion abundance for all the proteins within each of the 
mitochondrial preparations treated/not treated with nagarse from the Progenesis protein 
reports. The total ion abundances are in reference to alignments in Mascot search using 
SwissProt_02_2015 database for mus musculus. The ion abundances of the peptides 
associated with the enzyme nagarse are in reference to alignments in Mascot search using 
SwissProt_02_2015 database for bacillus licheniformis.  
Statistical analyses  
 Differences between MITO+ and MITO- across variables of interest were 
compared using paired t-test. Data are reported as means ±SEM. Significance was set at 
P < 0.05.  
Results 
Protein content of final mitochondrial suspension  
 Isolating mitochondria with nagarse decreased the protein concentration of the 
final mitochondrial suspension by 30%. The MITO+ preparation was 2.12 ± 0.23 mg 
protein ml-1 compared to 2.80 ± 0.37mg.ml-1 in MITO-. When these protein 
concentrations (mg/ml) are multiplied by their respective suspension volumes (ml), the 
total protein yield (mg “mitochondrial” protein) of the isolation procedure is calculated. 
When this is done, the MITO+ protein yield was 0.290 ± 0.03 mg, compared to a MITO- 
value of 0.386 ± 0.05 mg (Table 2-1). Thus, nagarse exposure reduced, by 25%, the total 
protein isolated (Table 2-1).
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Table 2-1. Total protein yield, enzyme specific activities, and indices of functional 
integrity of mitochondria isolated without and with nagarse. 
 MITO− MITO+ 
MITO+/MITO- 
(Fold Δ) P Value 
Total protein yield  
     mg 
0.386±0.05 0.290±0.03 0.75 0.02 
Citrate synthase activity 
     nmol.min−1.mg−1 
827.4±65.4 1232.9±83.5 1.49 0.0001 
State 3 JO 
     nmol.min−1.mg−1 
77.6±8.6 142.6±16.8 1.84 0.003 
State 4 JO 
     nmol.min−1.mg−1 
22.5±2.4 31.0±3.5 1.38 0.01 
State 3 JP 
     nmol.min−1.mg−1 
384.9±36.9 771.4±83.4 2.00 0.002 
RCR 3.6±0.4 4.6±0.4 1.30 0.002 
ADP/O 2.5±0.1 2.7±0.1 1.09 0.02 
Table 2-1. Values are means±SE; MITO+, mitochondria samples treated with nagarse; 
MITO−, mitochondria samples not treated with nagarse; total protein yield was calculated 
as the product of the protein concentration in the final mitochondrial suspension times the 
suspension volume; state 3 Jo, state 3 O2 consumption rate; state 4 Jo, state 4 O2 
consumption rate; state 3 Jp, state 3 ATP production rate. RCR, respiratory control ratio, 
is State 3 (maximum) Jo divided by State 4 (resting) Jo; State 3 Jp is the product of State 
3 Jo and the ADP/O ratio.
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Citrate synthase activity 
 Citrate synthase, the first enzyme of the citric acid cycle, is a sturdy matrix 
enzyme often used to assess muscle mitochondrial content. Expressed per mg protein in 
the final mitochondrial suspension, citrate synthase activity (U mg-1) was 49% higher 
when nagarse was included in the isolation procedure (Table 2-1). However, the total 
citrate synthase activity recovered in the final mitochondrial suspension, calculated by 
multiplying the Umg-1 by the total protein (mg) yield in the final suspension (see above), 
was not different in MITO+ (366.7 ± 53.0 nmol min-1) compared to MITO- (329.3±54.1 
nmol min-1) (Table 2-2).
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Table 2-2. Total yield of citrate synthase and respiratory activity of mitochondria isolated 
without and with nagarse. 
  
MITO− MITO+ 
MITO+/MITO- 
(Fold Δ) P Value 
Citrate synthase activity  
     nmol.min−1 329.3±54.1 366.7±53.0 1.11 0.110 
State 3 JO  
     nmol.min−1 31.1±5.7 42.5±7.5 1.37 0.010 
State 4 JO  
     nmol.min−1 9.1±1.8 9.1±1.3 1.00 0.980 
State 3 JP  
     nmol.min−1 153.5±27.5 229.5±38.8 1.49 0.010 
Table 2-2. Values are means±SE; MITO+, mitochondria samples treated with nagarse; 
MITO−, mitochondria samples not treated with nagarse; total yield of activity was 
calculated as the product of specific activity times the total protein yield (see mean values 
in Table 1); state 3 Jo, state 3 O2 consumption rate; state 4 Jo, state 4 O2 consumption 
rate; state 3 Jp, state 3 ATP production rate.
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Respiratory rates and respiratory control ratio  
 Mitochondrial O2 consumption (Jo) due to the combustion of Pyruvate + Malate + 
Glutamate (PMG Jo) requires the entire oxidative pathway of fully intact mitochondria, 
including several soluble matrix cofactors such as Coenzyme A and NAD+. Saturating 
ADP was added to stimulate the maximum O2 consumption rate (state 3 Jo). When 
mitochondria phosphorylate all of the added ADP to ATP, they transition to “resting” 
(state 4) respiration. Table 2-1 reports that nagarse treatment increased both state 3 Jo (by 
84%) and state 4 Jo (by 38%), when these values are expressed per mg protein (nmol O2 
min-1 mg-1). Thus, nagarse treatment especially increased State 3 Jo, while it increased 
State 4 more modestly. As a result, nagarse increased the respiratory control ratio 
(RCR=State 3 Jo/State 4 Jo) by 30% (Table 2-1). The total yield of State 3 Jo activity 
recovered in the final mitochondrial suspension was calculated as above for citrate 
synthase, by multiplying the respiration rates per mg by the total protein (mg) yield in the 
final suspension. Unlike citrate synthase, which was not statistically different, total state 
3 Jo was 37% higher in MITO+(42.5±7.5 nmol min-1) compared to MITO-(31.1±5.7 
nmol min-1) (Table 2-2). The total yield of State 4 Jo activity was essentially identical in 
MITO- and MITO+ (Table 2-2). 
ADP/O coupling and maximum ATP production  
 Nagarse exposure modestly improved, by 9%, the ADP/O ratio, 2.7±0.1 vs. 
2.5±0.1, in MITO+ vs. MITO-, respectively (Table 2-1). The product of State 3 Jo times 
the ADP/O yields the State 3 ATP production rate (State 3 Jp). Because both factors were 
elevated by nagarse treatment, State 3 Jp was dramatically (100%) higher in MITO+ 
compared to MITO-, 771.4±83.4 vs. 384.9±36.9 nmol ATP min-1 mg-1 respectively 
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(Table 2-1). Again, multiplying these protein-specific State 3 Jp values by the total 
protein (mg) yield indicated that nagarse exposure increased the total yield of State 3 Jp 
by 49%: 229.5±38.8 nmol ATP/min in MITO+ vs. 153.5±27.5 nmol ATP/min in MITO- 
(Table 2-2).  
Protein detection by SDS-PAGE and identification and quantification by mass 
spectrometry  
 Consistent with the Lowry protein determinations, nagarse treatment decreased 
the visually apparent protein detected using SDS-PAGE in representative MITO+ vs. 
MITO- preparations (Figure 2-2A). Mass spectrometry analysis of all samples also 
showed less protein, including mitochondrial protein, content in the MITO+ suspensions 
(Figure 2-2B). In MITO+ preparations approximately 83% of the total protein content 
was identified as mitochondrial proteins. In contrast, in MITO- preparations 
mitochondrial proteins could account for only approximately 73% of total protein. The 
ratio of identified MITO proteins versus non-MITO proteins was higher in MITO+ 
samples compared to MITO- (Figure 2-2C). Nagarse (apr; subtilisin Carlsberg; 
EC:3.4.21.62; UniProtKB accession number, Q65LP7) was essentially absent in the final 
suspensions of mitochondria subjected to nagarse treatment. In MITO+ preparations the 
tryptic peptide abundance of nagarse represented only 0.008% of the total peptide 
abundance. In MITO+ this value was 0.0002%.
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Figure 2-2. Protein abundance in mitochondrial suspensions isolated without and with 
nagarse. Protein abundance detected by SDS-PAGE/Coomassie Blue (A), HPLC-ESI-
MS/MS quantitative proteomics analysis to determine peptide ion abundance of 
mitochondrial and non-mitochondrial proteins in MITO+ and MITO− samples (B), and 
protein ratio of mitochondrial-to-non-mitochondrial protein in the same samples (C). 
Values are means±SE; MITO+, mitochondria samples treated with nagarse; MITO−, 
mitochondria samples not treated with nagarse; *P<0.05 between MITO+ and MITO-.
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Discussion 
 The major findings reported here are that nagarse exposure substantially reduced 
(by 25%) the protein yield in the final mitochondrial suspension, and proteomic analysis 
indicated that the elimination of non-mitochondrial protein accounted for much of this 
reduction. By removing non-mitochondrial protein, nagarse treatment increased 
mitochondrial enzyme and enzyme pathway protein-specific activities. Expressed per mg 
protein, nagarse treatment increased citrate synthase activity by 49% and State 3 Jo even 
more dramatically, by 84%. Moreover, nagarse also modestly increased the ADP/O ratio, 
so that, per mg protein, State 3 Jp improved by 100%. The data generally indicate that 
nagarse treatment effectively removes contaminating non-mitochondrial proteins and 
substantially improves indices of mitochondrial catalytic potential and energetic 
coupling.  
 The total isolated CS activity was not significantly affected by nagarse treatment, 
while nagarse increased the total yield of State 3 Jo by 37%, and State 3 Jp by 49%. The 
spectrophotometric assay of citrate synthase activity versus the polarographic assay of 
mitochondrial oxidative phosphorylation fueled by PMG, evaluate two vastly different 
parameters of mitochondrial structure and function. Citrate synthase is a high activity 
matrix enzyme with well-known stability (D’Souza & Srere, 1983), and is routinely 
measured in either whole tissue homogenates or mitochondrial suspensions in the 
presence of a detergent such as Triton X-100, as it was in the present study. In marked 
contrast, the oxidation of the substrate combination PMG, whether the mitochondria are 
“resting” or stimulated by saturating ADP, requires, at the least, the entire integrated 
oxidative pathway and, in particular, robust inner membrane structural integrity. It can be 
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argued that the different out-comes of the CS and Jo assays suggest that nagarse 
treatment somehow modified the first, slow speed, supernatant in away that protected 
mitochondrial units (vesicles) from damage during the subsequent high speed 
centrifugation and resuspension steps of the isolation procedure. This interpretation is 
developed below.  
 Whether mitochondria are partially damaged, have been briefly opened and then 
resealed, or are fully intact, citrate synthase activity may well remain unaffected. Thus, it 
can be envisioned that in the absence of nagarse treatment some mitochondria, both fully 
intact and partially damaged, in the first supernatant were subsequently further damaged 
during the course of the isolation procedure, but they nevertheless carried citrate synthase 
activity into the final suspension. Nagarse treatment, on the other hand, would be 
expected to proteolytically remove the activity of exposed citrate synthase in damaged 
mitochondria. The data of Table 2-2 indicate that these intact mitochondria in the final 
MITO+ suspension carry roughly similar citrate synthase as the MITO-. The net effect is 
that the total yield of citrate synthase activity in the final suspension is not significantly 
different. However, in MITO+ more of this citrate synthase activity reside in fully intact 
mitochondria, which are capable of coupled oxidative phosphorylation. The total yield of 
State 3 Jo was 37% higher and State 3 Jp activity was 49% higher in MITO+ final 
suspensions. In contrast, the total yield of State 4 Jo was essentially identical in the two 
preparations. Nagarse in the first supernatant may have somehow protected against 
mitochondrial damage during subsequent centrifugation and resuspension steps, perhaps 
by digesting non-mitochondrial proteins in some type of linkage (Boncompagni & Rossi, 
2009; de Brito & Scorrano, 2008) to mitochondria. In the absence of nagarse treatment, 
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during the high- speed centrifugations and pellet resuspensions these linkages somehow 
increased the likelihood of structural insult to mitochondrial vesicles. The damage was 
not severe enough to liberate citrate synthase from its matrix binding (D’Souza & Srere, 
1983), but was sufficient to preclude the development of the very high driving forces 
required for oxidative phosphorylation. Damaged organelles in MITO- preparations are 
consistent with the lower RCR and ADP/O values observed in MITO-. It therefore 
appears that nagarse promoted the release of mitochondria from non-mitochondrial 
protein, which was digested and resulted in less protein yield and less damage to 
mitochondria during isolation. Mass spectrometry data further support this interpretation. 
MITO- preparations had much greater abundance of non-mitochondrial proteins. In 
nagarse treated preparations, both mitochondrial and non-mitochondrial protein yields 
were reduced (Figure 2-2B). This suggests that sufficiently damaged mitochondria in the 
first supernatant were exposed to nagarse entry/attack, digested and did not make it into 
the final suspension. The mitochondria within a muscle cell are interconnected as a 
reticulum (network) (Amchenkova et al., 1988; Bach et al., 2003; Bakeeva et al., 1978; 
Glancy et al., 2015; Kirkwood, Munn, & Brooks, 1986). Mechanical homogenization, 
however gentle, of muscle tissue therefore must destroy this reticular structure, because 
electron micrographs of isolated mitochondria, for example those of Palmer et al. (Palmer 
et al., 1977), clearly show the isolated organelles as individual vesicles. During 
homogenization, as these vesicles form, some membrane damage and leakage of essential 
matrix cofactors (NAD, CoA, adenylates, etc.) into the isolation medium would be 
expected (Bremer, Wojtczak, & Skrede, 1972). Nevertheless, when these procedures are 
performed carefully by experienced hands, and particularly when nagarse is included in 
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the isolation procedure, the resulting vesicles are capable of nearly matching the 
maximum O2 consumption rates (U F Rasmussen & Rasmussen, 2000; Ulla F. 
Rasmussen, Vielwerth, & Rasmussen, 2004) and ATP free energy (Hitchins, Cieslar, & 
Dobson, 2001; Jeneson, Westerhoff, Brown, Van Echteld, & Berger, 1995; Kemp, 
Meyerspeer, & Moser, 2007) measured in intact muscle using Fick O2 mass balance and 
31P-MRS, respectively. Moreover, the isolated mitochondria also control respiration and 
ATP production over the same range of energy phosphate levels observed in vivo 
(Glancy, Willis, Chess, & Balaban, 2013; Jeneson, Westerhoff, Brown, Van Echteld, & 
Berger, 1995; Lefort et al., 2010; Messer, Jackman, & Willis, 2004). Thus, mitochondria 
isolated using mechanical homogenization and exposure to protease can be nearly as 
functional as mitochondria in vivo.  
Conclusions 
 Nagarse treatment of mitochondria removes non-mitochondrial proteins as well as 
proteins of damaged mitochondria, and improves indices of functional integrity and 
resulting protein-specific activities. 
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CHAPTER 3: PLASMA AMINO ACIDS STIMULATE UNCOUPLED RESPIRATION 
OF MUSCLE SUBSARCOLEMMAL MITOCHONDRIA IN LEAN BUT NOT OBESE 
HUMANS 
 
Katon A. Kras, Nyssa Hoffman, Lori R. Roust, Shivam H. Patel, Chad C. Carroll, 
Christos S. Katsanos 
 
Abstract 
 Obesity is associated with mitochondrial dysfunction in skeletal muscle. Skeletal 
muscle mitochondria are arranged as a reticulum; mitochondria in the periphery of the 
cell, directly beneath the sarcolemma, subsarcolemmal (SS) and mitochondria located in 
the interior of the cell proximal to myofibrils, intermyofibrillar (IMF). Obese individuals 
have reduced ATP production associated with early fatigability during activity and more 
sedentary lifestyle. SS mitochondria being more adaptable than IMF mitochondria, may 
be prone to metabolic changes in obesity, but better able to respond to treatments for 
obesity, such as increased protein intake/amino acids (AA). Increasing the plasma amino 
acid (AA) concentrations stimulates mitochondrial ATP production in lean individuals. 
Therefore, the objective of this study was to determine whether four-hour infusion of AA 
improves skeletal muscle mitochondria ATP production equally in healthy lean and obese 
adults; in other words we sought to determine whether acute elevation in plasma AAs 
enhances muscle mitochondrial respiration and ATP production in skeletal muscle 
mitochondria of obese adults. Using standard polarography techniques, we measured 
maximal oxygen consumption rates to assess SS and IMF mitochondria function during 
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saline (i.e., control) and AA infusions. Eligible participants were healthy lean (BMI, < 25 
kg/m2; age, 37 ± 3 yrs; n = 10) and obese (BMI > 30 kg/m2; age 35 ± 3 yrs; n = 11) 
subjects. The intervention in this study was a single trial of saline infusion followed by a 
four-hour AA infusion. SS and IMF mitochondria were isolated from muscle biopsies 
collected at the end of the saline and AA infusions. The main outcomes to this study 
revealed that mitochondrial ADP-stimulated respiration and ATP production rates 
increased following a four-hour AA infusion in SS mitochondria of lean (P < 0.05), but 
not obese, subjects. Furthermore, we show that four-hour AA infusion increased the 
uncoupled (i.e. non ADP-stimulated) respiration of SS mitochondria in the lean subjects 
only (P <0.05). AA infusion had no effect in any of these parameters on IMF 
mitochondria in either lean or obese subjects (P > 0.05). From these finding we conclude 
that increasing plasma amino acids concentrations enhances the capacity for respiration 
and ATP production of muscle SS mitochondria, but not IMF mitochondria, in lean 
individuals in parallel with increase in uncoupled respiration. However, neither of these 
parameters increases in muscle SS mitochondria or IMF mitochondria in obese 
individuals. In summary, amino acid infusion results in increased maximal oxygen 
consumption and uncoupled respiration in subsarcolemmal, but not intermyofibrillar 
mitochondria in lean, but not obese subjects. 
Introduction 
 Obesity is an underlying cause for diabetes, heart disease, and cancer. The 
financial burden on the healthcare system to treat obesity continues to rise as access to 
food increases in parallel with the adoption of more sedentary lifestyle. Mitochondria 
from skeletal muscle exist in a reticulum (Bakeeva, Chentsov YuS, & Skulachev, 1978; 
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Glancy et al., 2015; Kirkwood, Munn, & Brooks, 1986; Ogata & Yamasaki, 1997) and 
according to some evidence, obese individuals have reduced skeletal muscle 
mitochondrial function as indicated by lower citrate synthase activity (Machado et al., 
2012), reduced capacity for mitochondrial electron transport (Kelley, He, Menshikova, & 
Ritov, 2002), or ATP production (Abdul-Ghani et al., 2009). However, such differences 
in mitochondrial function are not evident when lean and obese subjects are matched for 
physical activity levels (Karakelides et al., 2010). Reduced physical activity in obese 
individuals (Cooper, Page, Fox, & Misson, 2000) may impair muscle mitochondrial 
function (Safdar et al., 2010) and exacerbate the metabolic consequences of obesity. 
Regardless of the mechanism(s) involved, diminished skeletal muscle mitochondrial 
function in obesity has causally been linked to insulin resistance (previously reviewed 
(Montgomery & Turner, 2014)). Skeletal muscle mitochondria are unique with respect to 
their arrangement within myocytes: mitochondria near the periphery of the cell are 
termed subsarcolemmal (SS) mitochondria and those near the myofibrils are termed 
intermyofibrillar (IMF) mitochondria. These two mitochondrial subpopulations are 
biochemically distinct (Palmer & Hoppelt, 1985). The previously reported differences in 
mitochondrial ATP production observed in muscle from obese could be specific to the 
population of skeletal muscle mitochondria studied. Furthermore the SS mitochondria has 
been shown to be more responsive to metabolic changes, compared to IMF mitochondria 
(Bizeau, Willis, & Hazel, 1998; Chomentowski, Coen, Radiková, Goodpaster, & Toledo, 
2011; Cogswell, Stevens, & Hood, 1993; Crescenzo et al., 2006; Koves et al., 2005). 
Consequently, metabolic changes associated with obesity may particularly affect the SS 
mitochondria. Muscle mitochondria have been previously studied relative to their 
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subcellular location, and with regards to their content/size (Samjoo et al., 2013) or 
substrate metabolism (Hoshino, Yoshida, Kitaoka, Hatta, & Bonen, 2013; Stefanyk et al., 
2011). To our knowledge there is limited evidence evaluating respiratory capacity 
separately in SS and IMF mitochondria when comparing lean and obese humans. In 
relevant evidence, Ritov et al (Ritov et al., 2005) have shown that electron transport chain 
activity is reduced in Type 2 Diabetes patients as well as obese adults in both SS and IMF 
muscle mitochondria, and in parallel with greater reduction in SS mitochondrial content. 
On the other hand, SS mitochondria show more pronounced improvements in function in 
response to interventions, such as exercise, than IMF mitochondria (Menshikova et al., 
2006). Therefore, studying SS and IMF mitochondria independently allows for a more 
detailed exploration of the mechanisms that can lead to alterations in energy metabolism 
in the muscle of obese individuals. Improving mitochondrial metabolism has been 
proposed as a novel approach to treating obesity and insulin resistance (Montgomery & 
Turner, 2014). 
 Practical treatments for obesity include nutritional and exercise interventions. 
Lifestyle interventions to treat obesity such as nutrition, specifically the increased intake 
of protein/amino acids have been shown to effect skeletal muscle mitochondrial function 
(Guillet et al., 2009; Tatpati et al., 2010). Increased availability of amino acids has been 
shown to promote protein synthesis in skeletal muscle at the total (Bohé, Low, Wolfe, & 
Rennie, 2003; Guillet et al., 2009; Katsanos, Kobayashi, Sheffield-Moore, Aarsland, & 
Wolfe, 2005, 2006; Volpi, Kobayashi, Sheffield-Moore, Mittendorfer, & Wolfe, 2003) as 
well as mitochondrial protein levels (Bohé et al., 2003; Guillet et al., 2009; Stump, Short, 
	 	 	47 
Bigelow, Schimke, & Nair, 2003; Tatpati et al., 2010); resulting in higher skeletal muscle 
mitochondrial ATP production (Stump et al., 2003; Tatpati et al., 2010). 
 Plasma amino acids (AAs), in addition to their well-known effects on stimulating 
mitochondrial protein synthesis (Katsanos et al., 2006), improve mitochondrial ATP 
production of SS mitochondria of young healthy lean subjects (Tatpati et al., 2010). 
Generally, SS mitochondria appear more responsive than IMF mitochondria to 
physiological perturbations induced by muscle use (or disuse) (Hood, 2001). To our 
knowledge, no studies have evaluated the effects of increasing the plasma AAs on the 
function of IMF mitochondria in humans, and, more importantly, how responses in SS 
and IMF mitochondria may differ between lean and obese humans. Moreover, the 
metabolism of certain AAs, such as the branched-chain AAs (BCAAs), is impaired in 
skeletal muscle in obesity (Lerin et al., 2016), which could differentially impact the 
effects of plasma AA availability on mitochondrial function. Therefore, we hypothesized: 
1) the AA would stimulate ATP production in skeletal muscle SS mitochondria only and 
2) the stimulatory effect of AA would be lower in obese compared with lean adults. 
Measurements of citrate synthase activity, hormones and substrates were used to 
elucidate the underlying mechanisms responsible for improving capacity of ATP 
production in skeletal muscle mitochondria. These findings may be translated into 
interventions to improve energy metabolism in skeletal muscle from obese individuals. 
Therefore, determining interventions and the mechanisms, which improve capacity of 
ATP production in skeletal muscle from obese individuals is expected to have the 
following benefits: 1) decrease fatigability, 2) increase levels of activity, and 3) help 
improve overall skeletal muscle energy metabolism in obese individuals. 
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 Our objective was to compare the effects of increased plasma AA concentrations 
on SS and IMF mitochondrial function, specifically as it relates to oxygen consumption 
and ATP production in lean and obese individuals. To this end, we hypothesized that 
elevated plasma AA concentrations will stimulate oxygen consumption and ATP 
production in skeletal muscle SS mitochondria only, and that this effect will be observed 
in lean but not obese subjects.  
Methods 
Subjects 
 Ten healthy sedentary lean (male = 4, females = 6; age = 37±3.1 years; BMI = 
22.0±0.7 kg/m2; Body fat = 23.8±2.6%) and eleven healthy sedentary obese (male = 6, 
females = 5; age = 35±3.1 years; BMI = 34.5±1.1 kg/m2; Body fat = 33.7±2.2%) 
individuals participated in this study. The Institutional Review Board at Mayo Clinic 
approved the studies and all experimental procedures were performed in the Clinical 
Studies Infusion Unit (CSIU) at Mayo Clinic in Scottsdale, Arizona. The purpose, design, 
and the risks associated with this study were explained to each subject before obtaining 
written consent. Participants were determined healthy based on screening procedures that 
involved medical history, routine physical examination, and standard laboratory tests, 
which included blood metabolic panel, urinalysis, and a 2-hour oral glucose tolerance test 
(OGTT). Body fat was determined using bioelectrical impedance analysis (BIA 310e, 
Biodynamics Corporation, Seattle, WA). Maximal oxygen uptake (VO2max) was 
measured (Ultima™ Series, MGC Diagnostics Corporation, Saint Paul, MN) on a 
separate day following the screening by using an incremental (30 Watts/min) cycle 
ergometer (Lode Corival, Lode B.V., Groningen, Netherlands) test to exhaustion. Subject 
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characteristics are shown in Table 3-1. Participants returned to the CSIU on a separate 
day from their screening visit for the main experiment, which included intravenous 
infusion of saline followed by infusion of AAs and collection of blood and muscle 
samples.
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Table 3-1 Subject anthropometric and metabolic characteristics. 
Characteristic Lean Obese P Value 
Gender (M/F) 4/6 6/5  
Age, years 37 ± 3 35 ± 3 0.5970 
Body Weight, kg 62 ± 3 103 ± 4 < 0.0001 
BMI, kg/m2 22 ± 1 34 ± 1 < 0.0001 
Body fat (%) 24 ± 3 34 ± 2 0.0097 
FFM, kg 43 ± 3 68 ± 2 < 0.0001 
VO2max, ml/kg FFM/min 35 ± 7 34 ± 7 0.9000 
Matsuda Index 9.2 ± 0.9 4.5 ± 1.2 0.0076 
2-hr OGTT glucose, mmol/l 4.9 ± 0.1 5.4 ± 0.2 0.0076 
HbA1c, (%) 5.3 ± 0.1 5.6 ± 0.1 0.0517 
Table 3-1. Data are presented as mean ± SEM; BMI, body mass index; FFM, fat free 
mass; VO2max, maximal oxygen uptake; Matsuda index, insulin sensitivity index 
calculated from the plasma glucose and insulin responses during an oral glucose tolerance 
test (OGTT).
	 	 	51 
Experimental Design 
 Volunteers arrived at the CSIU at approximately 0630 h following an overnight 
fast. All subjects were instructed to refrain from any form of exercise for the 3-days prior 
to the study. An intravenous line was inserted into an antecubital vein for infusions, while 
a second intravenous line was placed in a dorsal hand vein to collect arterialized blood 
samples (i.e., heated-hand technique) (Sonnenberg & Keller, 1982). After that, a saline 
infusion was started (time 0) and continued for 300 min. At 300 min, an amino acid 
mixture infusion (15% Clinisol; Baxter Healthcare Corporation, Deerfield, IL) was 
started with a priming dose, 82 mg kg/FFM, and then maintained at 240 mg kg/FFM/hr 
for 240 min (i.e., 540 min from the beginning of the experiments). Specifically, there 
were two periods in the experimental protocol; one describes the response of skeletal 
muscle mitochondrial function at the end of the saline infusion and the second describes 
skeletal muscle mitochondrial function at the end of amino acids infusion period. Blood 
samples were collected at 60 minutes and 300 minutes after the start of the saline 
infusion, and at 30 minutes and 240 minutes after the initiation of the AA mixture 
infusion. Muscle samples were collected at the end of the saline and AA infusion periods 
to evaluate skeletal muscle mitochondria function.  
 A Bergström biopsy needled was used to collect percutaneous muscle biopsies 
(~100 mg) of the vastus lateralis under local anesthesia (lidocain, 2%). After removing 
the blood, fat and visible connective tissues, the muscle biopsy was placed into a pre-
massed beaker containing 2 ml of ice-cold Solution I (modified Chappell-Perry Medium I 
(Solution I; mM): 100 KCl, 40 Tris-HCl, 10 Tris-Base, 5 MgCl2, 1 EDTA, 1 ATP, pH 
7.5), reweighed, and the wet muscle mass was calculated. The mean vastus lateralis 
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masses, collected at the end of the saline and AA infusion periods, from lean and obese 
individuals were 105.0±8.9 vs. 115.6±6.9 and 106.8±12.3 vs. 114.7±6.3 (mg), 
respectively. There were no significant differences in the masses of muscle biopsies 
collected in either the lean or obese groups following any of the study periods as 
determined by Unpaired t test; data represents mean muscle mass ± SEM; P > 0.05. 
Isolation of skeletal muscle mitochondria 
 All procedures were carried out on ice or at 4°C and all centrifugations were 10 
min in duration. Muscles were minced with scissors in 9 volumes of ice-cold Solution I 
(mM; 100 KCl, 40 Tris-HCl, 10 Tris-Base, 5 MgCl2, 1 EDTA, 1 ATP, pH 7.5.), and 
gently homogenized by hand using a ground glass-to-glass Potter-Elvehjem homogenizer 
(5 passes). The homogenate was centrifuged at 800 x g to obtain the supernatant (SN 1) 
containing mechanically released SS mitochondria (Figure 3-1). The pellet from the 
initial 800 x g centrifugation, Potter-Elvehjem Pellet (PEP), containing IMF 
mitochondria, was subjected to incubation with Nagarse (Type XXIV, Sigma, P-8038). 
Nagarse was prepared using Solution I and added (5 mg·g-1 WW) to the PEP to liberate 
IMF mitochondria. After a 7-min incubation, 1 ml of Solution I was added to the digested 
PEP, to stop the enzymatic digestion. The resuspended PEP was then centrifuged at 800 x 
g to separate the non-mitochondrial proteins and membranes from IMF mitochondria. 
This supernatant (SN 2) containing IMF mitochondria was transferred to a new tube. The 
SN 1 containing SS mitochondria and the separate SN 2 containing IMF mitochondria 
were centrifuged at 14,000 x g to obtain two mitochondrial pellets, SS mitochondria and 
IMF mitochondria. After discarding the supernatant, each of the mitochondrial pellets 
were resuspended in 0.5 ml of Solution II (mM): 100 KCl, 40 Tris-HCl, 10 Tris-Base, 5 
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MgCl2, 1 EDTA, 0.2 ATP, at pH 7.5. Following centrifugation at 7000 x g, the 
supernatants were discarded and the mitochondrial pellets were resuspended a third time 
in 0.5 ml of Solution II. After the final centrifugation at 4000 x g and removal of the 
supernatant, the two final mitochondrial pellets (i.e. SS mitochondria and IMF 
mitochondria) were each resuspended in identical volumes of mannitol-sucrose buffer 
containing (mM) 220 Mannitol, 70 Sucrose, 10 Tris-HCl, 1 EGTA, pH 7.40. The protein 
content in the final mitochondrial preparations was determined by the method of Lowry 
(Lowry, Rosebrough, Farr, & Randall, 1951). Citrate synthase (CS) activity in the same 
preparations was determined spectrophotometrically at 37°C using procedures we have 
previously described in chapter 2 (Kras et al., 2016).
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Figure 3-1. A schematic workflow for isolating skeletal muscle subsarcolemmal (SS) and 
intermyofibrillar (IMF) mitochondria from lean and obese individuals; SN – supernatant.
4 showing strategi s for isolation of skeletal muscle
subsarc lemm l (SS) and intermyofibrillar (IMF) mitochondria from lean and obese 
individuals; SN - supernatant.
Figure 4-1. Schematic workflow showing strategies for isolation of skeletal muscle subsarcolemmal (SS) and intermyofibrillar 
(IMF) mitochondria and proteomics from lean and obese individuals; SN - supernatant. Quantification of proteins performed by 
spectra counting and normalization of spectral abundance.
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Assays for mitochondrial O2 consumption and ATP production 
 Freshly isolated mitochondria were assayed for O2 consumption rate (Jo) and 
ATP production rate (Jp). O2 consumption was measured polarographically in a 
respiration chamber (Hansatech Instruments, Norfolk, UK) at 37°C following general 
procedures we have previously described (Kras et al., 2016) and described in chapter 2. 
Complex-I-mediated and complex-II-mediated mitochondrial respiration were assessed 
with saturating amounts of either Malate (1mM) +Pyruvate (1mM) +Glutamate (10mM) 
(MPG) or Succinate (10mM) (SUCC), respectively. Aliquots of mitochondrial 
suspension were added to 0.230 ml of respiration media, adapted from Wanders, 
(Wanders, Groen, Van Roermund, & Tager, 1984) containing (in mM) 100 KCl, 50 
MOPS, 100 Glucose, 10 K2PO4, 10 MgCl2, 1 EGTA, and 0.2% BSA, pH 7.00. The MPG 
or SUCC substrates were added to the respiration chamber, and state 2 Jo was followed 
(respiration primarily due to proton leak). The addition of ADP to give a final 
concentration of 0.67 mM stimulated state 3, (maximal) Jo. Phosphorylation of this ADP 
resulted in state 4 Jo (Estabrook, 1967), and the respiratory control ratio (RCR) was 
calculated as state 3 Jo/state 4 Jo. The ADP/O ratio was determined as previously 
described (Estabrook, 1967). The State 3 (maximal) rate of ATP production was 
calculated as previously described (Kras et al., 2016). 
Determination of muscle mitochondrial DNA content 
 Total DNA was isolated from whole muscle homogenates stored at -80°C, using 
TRI-Reagent® (T9424) (Sigma-Aldrich; Molecular Research Center), and by following 
the manufacturer’s instructions. DNA was quantified using the NanoDropTM 1000 
Spectrophotometer Thermo Fisher Scientific (Wilmington, DE, USA). Concentration was 
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determined by the absorbance at 260 nm, and purity was assessed using the 260:280 ratio. 
PCR for the detection of mitochondrial NADH-ubiquinone oxidoreductase chain 2 
(MTND2) and nuclear beta-actin (ACTB) (Vogel et al., 2008) was performed in duplicate 
using the Applied Biosystems ABI 7900HT sequence detection instrument and software. 
TaqMan® Fast Universal PCR master mix reagents and the Assay-On-DemandTM gene 
expression primer pair and probes (Thermo Fisher Scientific) for MTND2 
(Hs02596874_g1) and ACTB (Hs03023880_g1), were added to 20 ng DNA and 1 ng of 
DNA, respectively. All samples were run in duplicate for each gene. A DNA standard 
curve was performed to optimize amplification. Reactions were run with the following 
thermal cycling conditions: 50°C for 2 min, 95°C for 10 min followed by 40 cycles at 
95°C for 15 s, and 60°C for 60 s. The threshold cycle number (Ct) was calculated using 
SDS software v.2.3 (Applied Biosystems) and an automatic setting of the baseline. These 
values were used for the calculation of the mitochondrial DNA copy numbers (mtDNA) 
expressed as 2∆Ct, and where ∆Ct = CtACTB - CtMTND2, and as described previously 
(Ritov et al., 2005; Szuhai et al., 2001). 
Mitochondrial respiration experiments of isolated rodent mitochondria treated with 
amino acids 
 All procedures were in accordance with the guidelines regarding the care and use 
of animals by the Institutional Animal Care and Use Committee at Mayo Clinic. Three 
C57BL/6J mice, 10-12 weeks old, were used for the experiments. Mice were euthanized 
by isoflourane inhalation and cervical dislocation. The left and right gastrocnemii were 
removed and immediately placed on an ice-cold petri dish, which was pre-rinsed with 
ice-cold Solution I (composition described above in “Isolation of skeletal muscle 
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mitochondria”). Mitochondrial isolation and measurement of mitochondrial respiration 
followed the procedures we describe for the human tissue. Only subsarcolemmal 
mitochondria were isolated for this set of experiments. After the isolation, the 
mitochondrial fraction was divided equally into two separate tubes. Mitochondrial protein 
content in each tube was determined by Lowry as previously described (Lowry et al., 
1951) and was not different between isolation preparations from either SS mitochondrial 
fraction. One of the fractions was treated with the amino acids found in the amino acid 
solution infused in the human experiments, while the other was not (i.e., control). For the 
fraction treated with the amino acids, 40 µg of isolated mitochondrial protein was 
incubated with the amounts of amino acids found in 47 µl of the infused amino acid 
solution (15% Clinisol; Baxter Healthcare Corporation, Deerfield, IL). These amino acid 
amounts were based on theoretical calculations, and in a way that approximate exposure 
of muscle mitochondria to amino acids at concentrations measured in plasma during the 
amino acid solution infusion. Protein yield (mg.g-1) in either of the final isolation 
preparations of SS mitochondria not treated with and treated with amino acids was not 
different; 6.3 ± 0.7 versus 5.49 ± 0.4, (n=3). A workflow diagram is presented in Figure 
3-2.
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Figure 3-2. Isolation and amino acids treatment in isolated mouse muscle mitochondria. 
A flow diagram depicting the preparation of mechanically released subsarcolemmal (SS) 
mitochondria either exposed (SS2) or not exposed (SS1) to a 15% mixture of amino acids 
(AA). Details are given in the methods section of this chapter titled “Mitochondrial 
respiration experiments of isolated rodent mitochondria treated with amino acids”; (SN, 
Supernatant).
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Fig. Isolation and treatment of the muscle mitochondria. A flow diagram depicting the preparation of mechanically released 
subsarcolemmal (SS) mitochondria either exposed (SS2) or not exposed (SS1) to a 15% mixture of amino acids (AA). Details 
are given in the “Methods in section of this chapter titled .” (SN, Supernatant)
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 Mitochondrial fractions remained on ice until mitochondrial respiration 
measurements were performed at approximately 90 minutes following the treatment of 
the isolated mitochondria with the amino acids (preliminary experiments showed robust 
differences between control and amino acid-treated mitochondria after treatment of 
mitochondria with amino acids for at least 90 minutes). Mitochondrial respiration 
measurements were performed in triplicate (and in a random order between control and 
amino acid-treated mitochondria) from mitochondria isolated from the three mice, and by 
following the procedures we described in the methods section of above,  “Assays for 
mitochondrial O2 consumption and ATP production”. 
Plasma hormone, glucose and amino acid concentrations 
 Arterialized blood samples were analyzed for concentrations of plasma insulin 
and C-peptide using commercially available kits (ALPCO Diagnostics, Salem, NH) and 
glucose using an automated glucose analyzer (STAT 2300; Yellow Springs Instruments). 
Concentrations of the plasma AAs were measured using high-performance liquid 
chromatography (HPLC). In brief, plasma samples for the determination of AA 
concentrations were treated with an equal volume of 10% trichloracetic acid, followed by 
the derivatization of the samples and standards with o-phthalaldehyde (Carroll et al., 
2005; Liu, 2000). Derivatized samples and standards were injected onto an Agilent 1100 
Series HPLC system (G1312A and G1329A, Agilent Technologies, Santa Clara, CA, 
USA), and separation of AAs was achieved using a Shimadzu C18, 50mm x 4.6mm 
column (Shimadzu Scientific Instruments, Columbia, MD, USA). Peaks were monitored 
at 230nm excitation/450nm emission (Agilent Technologies, G1321A). The 
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concentration of individual AAs was determined by comparison with a standard curve 
developed from known AA concentrations of each AA. 
Statistical analysis 
 Data are presented as means ± SEM. Area under the curve (AUC) values for 
variables of interest were calculated using the trapezoidal rule. Two-way with repeated 
measures ANOVA was used to test for the main effects of AAs and obesity, as well as 
their interaction on the variables of interest. Bonferroni correction was performed for 
multiple comparison tests. Non-paired two-tailed t tests were used for single 
measurements between lean and obese groups. Statistical significance was set at P < 0.05. 
Analyses were performed using the GraphPad Prism7 statistical software (GraphPad 
Software, San Diego, CA). 
Results 
Amino acid concentrations 
 Individual plasma AA (Aspartate, Glutamine, Asparagine, Serine, Glutamine, 
Threonine, Arginine, Tyrosine, Methionine, Valine, Phenylalanine, Isoleucine, Leucine) 
concentrations increased 2- to 6-fold in response to the AA mixture infusion (P < 0.05) in 
both lean and obese subjects (Table 3-2). The sum of the individual plasma AA 
concentrations, BCAA concentrations, and essential AA (EAA) concentrations, were all 
increased (P < 0.001) during the AA infusion when compared to the saline infusion in 
both lean and obese subjects (Figure 3-3).
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Table 3-2. Plasma amino acids concentrations during saline and following amino acids 
infusion periods between lean and obese subjects. 
 
Lean Obese 
Amino Acid Saline Infusion AA Infusion Saline Infusion AA Infusion 
Aspartate 5±0 21±3a 12±1 31±3a 
Glutamate 54±7 133±20c 148±7 172±24b 
Asparagine 28±3 53±7c 48±3 43±2d 
Serine 128±14 209±21c 196±5 183±18c 
Glutamine 389±51 595±68c 786±46 525±39c 
Threonine 179±24 334±41b 300±24 362±43a 
Arginine 92±10 271±26a 138±3 263±29a 
Tyrosine 55±5 85±9d 132±3 108±13a 
Methionine 60±11 208±32c 114±12 299±42c 
Valine 236±29 609±56a 474±21 718±69b 
Phenylalanine 60±7 209±23b 110±4 297±29a 
Isoleucine 73±15 221±19b 148±7 265±25a 
Leucine 132±25 355±27a 244±9 387±37a 
Table 3-2. Plasma amino acids concentations (µmol.L-1) measured during saline and 
following amino acid infusion periods between lean and obese (n=10, lean) (n=11, 
obese). Data presented as mean ± SEM. Two-way with repeated measures ANOVA was 
used to analyze the data. Bonferroni correction was performed for multiple comparison 
tests (aP < 0.0001, bP <0.001, cP < 0.01, dP < 0.05 versus saline infusion). 
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Figure 3-3. Sum of total amino acid (AA), essential amino acid (EAA), and branched-
chain amino acid (BCAA) concentrations (µmol.L-1) at the initiation of the experiments (t 
=60), at the end of the saline infusion period (t=300), 30 min after the start of the amino 
acid infusion (t=330), and at the end of the amino acid infusion period (t=540); A) all 
detected plasma amino acids (AA), C) essential amino acids (EAA), and E) branched-
chain amino acids (BCAA) measured in plasma during saline or following amino acids 
infusion periods. Corresponding area under the curve (AUC) values (µmol.L-1⋅h) 
describing the B) AA , D) EAA, and F) BCAA responses during the saline and AA 
infusion periods. Data is presented as mean ± SEM. Two-way with repeated measures 
ANOVA was used to analyze the data. Bonferroni correction was performed for multiple 
comparison tests (***P < 0.001, versus saline infusion).
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Hormones and glucose concentrations 
Insulin 
 Plasma insulin responses during the saline and AA infusions are shown in Figure 
3-4A. ANOVA revealed significant main effects for obesity (P < 0.001) and AAs (P < 
0.001), as well as their interaction (P < 0.01) on the calculated plasma insulin AUC 
values. Multiple comparison tests indicated that plasma insulin AUC was greater in 
response to AA infusion when compared to that during the saline infusion within the 
obese group only (Figure 3-4B). 
C-peptide 
 Plasma C-peptide responses during the saline and AA infusions are shown in 
Figure 3-4C. ANOVA revealed significant main effects for obesity (P < 0.05) and AAs 
(P < 0.001), as well as their interaction (P < 0.05) on the calculated C-peptide AUC 
values. Multiple comparisons tests showed that C-peptide AUC values were greater 
within both lean and obese groups during the AA infusion when compared to the saline 
infusion (Figure 3-4D). 
Glucose 
 Plasma glucose responses during the saline and AA infusions are shown in Figure 
3-4E. Plasma glucose AUC increased significantly during AA infusion when compared to 
that during saline infusion within the obese group only (Figure 3-4F).
	 	 	64 
 
Figure 3-4. Hormone and glucose concentrations. Measurements were performed at the 
initiation of the experiments (t =60), at the end of the saline infusion period (t=300), 30 
minutes after the start of the AA infusion (t=330), and at the end of the AA infusion 
period (t=540) for either A) insulin (pmol.L-1), C) C-peptide (nmol.L-1), or E) glucose 
(mmol.L-1). The corresponding area under the curve (AUC) values for either B) insulin 
(pmol.L-1⋅h) or D) C-peptide (nmol.L-1⋅h) describing the hormone and F) glucose 
responses during the saline and AA infusion periods. Data is presented as mean ± SEM. 
Two-way with repeated measures ANOVA was used to analyze the data. Bonferroni 
correction was performed for multiple comparison tests (***P < 0.001, **P < 0.01, *P < 
0.05 versus saline infusion, unless otherwise shown). 
0 100 200 300 400 500 600
0
100
200
300
400
Time (min)
In
su
lin
 (p
m
ol
.L
-1
)
Obese
Lean
A Saline Infusion AA Infusion
0 100 200 300 400 500 600
0.0
0.5
1.0
1.5
2.0
Time (h)
C
-p
ep
tid
e 
(n
m
ol
.L
-1
)
Obese
Lean
C Saline Infusion AA Infusion
0 100 200 300 400 500 600
0.0
0.5
4.0
4.5
5.0
5.5
6.0
Time (min)
G
lu
co
se
 (m
m
ol
.L
-1
)
Obese
Lean
E Saline Infusion AA Infusion
LEAN OBESE0
300
600
900
1200
1500
1800
In
su
lin
 A
U
C
(p
m
ol
.L
-1
⋅ h
)
Saline Infusion
AA Infusion
***
***
B
LEAN OBESE0
2
4
6
8
10
12
14
C
-p
ep
tid
e 
A
U
C
(n
m
ol
.L
-1
⋅h
)
Saline Infusion
AA Infusion
***
***
**
D
Lean Obese0
10
20
30
40
G
lu
co
se
 A
U
C
(n
m
ol
.L
-1
⋅h
)
Saline Infusion
AA Infusion
*
F
P = 0.07
	 	 	65 
Mitochondrial protein and citrate synthase activity 
 No significant main effects or interaction were found for protein concentration in 
either the SS or IMF mitochondrial fractions (P > 0.05; Table 3-3). Similarly, no 
significant main effects or interaction were found for citrate synthase activity, a marker of 
mitochondrial content (Larsen et al., 2012), or citrate synthase specific activity in either 
the SS or IMF mitochondrial fractions (P > 0.05; Table 3-3). Furthermore, no differences 
were found for mtDNA content between lean and obese subjects (Figure 3-5). These 
findings for comparable muscle mitochondria content between lean and obese are in line 
with those from other investigations with subjects of similar age (Fisher-Wellman et al., 
2014; Karakelides et al., 2010; Samjoo et al., 2013).
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Table 3-3. Protein and citrate synthase activity yields as well as citrate synthase specific 
activity in the subsarcolemmal and intermyofibrillar mitochondrial fractions during saline 
(i.e., control) and amino acid infusions. 
  Lean Obese 
  Saline Infusion 
AA 
Infusion 
Saline 
Infusion 
AA 
Infusion 
Protein (mg·g wet muscle-1)     
Subsarcolemmal 3.1 ± 0.2  3.1 ± 0.2 3.2 ± 0.4  2.8 ± 0.4 
Intermyofibrillar 2.1 ± 0.4  2.0 ± 0.3 2.2 ± 0.3  2.4 ± 0.4 
CS activity (µmol·min-1·g-1 wet muscle)     
Subsarcolemmal 2.2 ± 0.2  2.1 ± 0.3 2.2 ± 0.3  1.8 ± 0.3 
Intermyofibrillar 1.3 ± 0.2  1.5 ± 0.3 1.5 ± 0.2  1.6 ± 0.2 
CS specific activity (µmol·min-1·mg-1)     
Subsarcolemmal 0.8 ± 0.1  0.8 ± 0.1 0.7 ± 0.1  0.6 ± 0.1 
Intermyofibrillar 0.8 ± 0.1  0.8 ± 0.1 0.7 ± 0.1  0.7 ± 0.1 
Table 3-3. Protein yield and enzyme activities determined in subsarcolemmal and 
intermyofibrillar mitochondria during saline and following amino acids infusion periods 
between lean and obese. No significant effects were detected in any of the measurements 
for protein yield (mg·g wet muscle-1), total citrate synthase activity ((µmol·min-1·g-1 wet 
muscle), or citrate synthase specific activity (µmol·min-1·mg-1), during saline or 
following amino acids infusion periods in either group. Data is presented as mean ± 
SEM; P > 0.05; CS, citrate synthase. Two-way with repeated measures ANOVA was 
used to analyze the data.
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Figure 3-5. Baseline mitochondrial DNA (mtDNA) copy numbers between the lean and 
obese subjects using primers and probes directed to mitochondrial NADH-ubiquinone 
oxidoreductase chain 2 (MT-ND2) and normalized to nuclear beta-actin (ACTB). Data 
presented as mean ± SEM.
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 Maximal (state 3) Jo and ATP production 
 We detected no significant main effects for either obesity or AAs on state 3 JO in 
SS mitochondria, and when using either malate+pyruvate+glutamate (MPG) or succinate 
(SUCC) substrates (P > 0.05). However, there was significant interaction between factors 
(P < 0.01). Multiple comparison tests revealed increase in state 3 JO in the lean, but not 
obese, subjects in response to the AA infusion (Figure 3-6A and C). Similar to the 
finding in state 3 JO in SS mitochondria, state 3 JP increased in the SS mitochondria using 
MPG, and trending towards significance using SUCC (P=0.066), in lean, but not obese, 
subjects (Figure 3-6E and G). Also, the findings were the same when state 3 JO and JP 
were expressed relative to muscle wet weight instead of mitochondrial protein (Figure 3-
7). No significant differences were detected in state 3 JO and JP for the IMF mitochondria 
within or between groups (P > 0.05; Figure 3-6, Figure 3-7; right panels). 
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Figure 3-6. State 3 O2 consumption (State 3 JO) and ATP production (State 3 JP) per 
milligram (mg) of isolated protein. State 3 JO and JP of subsarcolemmal (left side) and 
intermyofibrillar (right side) mitochondria were measured at the end of the saline (Saline 
Infusion) and AA (AA Infusion) infusion periods. State 3 JO and JP were measured in the 
presence of Malate (1 mM) + Pyruvate (1 mM) + Glutamate (10 mM) (MPG) or 
Succinate (10 mM) (SUCC) as substrates, and maximal rates for JO and JP were 
stimulated by addition of ADP (0.67 mM). Data is presented as mean ± SEM. Two-way 
with repeated measures ANOVA was used to analyze the data. Bonferroni correction was 
performed for multiple comparison tests (**P < 0.01, *P < 0.05 versus saline infusion).
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Figure 3-7. State 3 O2 consumption (State 3 JO) and ATP production (State 3 JP) per gram 
(g) of wet muscle. State 3 JO and JP of subsarcolemmal (left side) and intermyofibrillar 
(right side) mitochondria were measured at the end of the saline (Saline Infusion) and AA 
(AA Infusion) infusion periods. State 3 JO and JP were measured in the presence of 
Malate (1 mM) + Pyruvate (1 mM) + Glutamate (10 mM) (MPG) or Succinate (10 mM) 
(SUCC) as substrates, and maximal rates for JO and JP were stimulated by addition of 
ADP (0.67 mM). Data is presented as mean ± SEM. Two-way with repeated measures 
ANOVA was used to analyze the data. Bonferroni correction was performed for multiple 
comparison tests (**P < 0.01, *P < 0.05 versus saline infusion). 
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“Resting” (states 2 and 4) JO 
 State 2 JO of SS mitochondria did not differ between lean and obese prior to the 
AA infusion, but it increased in the lean subjects only in response to the AA infusion 
(Figure 3-8A). State 4 JO of SS mitochondria did not differ between lean and obese prior 
to the AA infusion, but it increased in the lean subjects only in response to the AA 
infusion (Figure 3-8E and G). No differences were detected for either state 2 JO or state 4 
JO in the IMF mitochondria either within or between groups (P > 0.05; Figure 3-8; right 
panel).  
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Figure 3-8. State 2 (State 2 JO) and state 4 (State 4 JO) O2 consumption. State 2 JO and 
state 4 JO of subsarcolemmal (left side) and intermyofibrillar (right side) mitochondria 
were measured at the end of the saline (Saline Infusion) and AA (AA Infusion) infusion 
periods. State 2 JO was measured in the presence of Malate (1 mM) + Pyruvate (1 mM) + 
Glutamate (10 mM) (MPG) or Succinate (10 mM) (SUCC) as substrates. State 4 JO was 
measured following state 3 JO after depletion of ADP in the medium. Data is presented as 
mean ± SEM. Two-way with repeated measures ANOVA was used to analyze the data. 
Bonferroni correction was performed for multiple comparison tests (***P < 0.001, *P < 
0.05 versus saline infusion).
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Respiratory control ratio (RCR) and ratio of phosphorylation of ADP to Oxygen 
(ADP/O) 
 ANOVA showed significant main effect of AAs on the calculated respiratory 
control ratio (RCR) (i.e., state 3 JO/state 4 JO) in SS mitochondria with MPG (P < 0.01). 
Multiple comparison tests indicated an ~ 30% decrease in RCR in response to the AA 
infusion in the lean subjects only (Figure 3-9A). No significant differences were detected 
for RCR in the IMF mitochondria within or between groups (P > 0.05) (Figure 3-9; right 
panels). ADP/O data are presented in Figure 3-9E thru H. ANOVA showed a significant 
main effect of AAs on ADP/O in SS mitochondria with MPG (Figure 3-9E) (P < 0.01). 
Multiple comparison tests indicated significant increase in ADP/O in response to AA in 
the obese subjects only (Figure 3-9E). No significant differences were detected for 
ADP/O in the IMF mitochondria within or between groups (Figure 3-9; right panel) (P > 
0.05). 
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Figure 3-9. Respiratory control (RCR); (state 3 JO/state 4 JO) and ADP/O ratios. RCR and 
ADP/O were measured in the presence of Malate (1 mM) + Pyruvate (1 mM) + 
Glutamate (10 mM) (MPG) or Succinate (10 mM) (SUCC) as substrates; Data presented 
as mean ± SEM. Two-way with repeated measures ANOVA was used to analyze the 
data. Bonferroni correction was performed for multiple comparison tests (**P < 0.01, *P 
< 0.05 versus saline infusion).
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Maximal (state 3) Jo, ATP production (JP) from isolated subsarcolemmal mitochondria 
from rodent gastrocnemius treated with amino acids 
 Representative oxygraph traces are shown in Figure 3-10A and B. The state 3 JO 
of SS mitochondria not treated with 15% mixture of amino acids (-AA) was lower 
compared to the state 3 JO of SS mitochondria treated with amino acids (+AA) when 
using either malate+pyruvate+glutamate (MPG) (Figure 3-10C and D). As expected, the 
ATP production rate was also higher in SS mitochondria treated with amino acids when 
compared to SS mitochondria not treated with amino acids (Figure 3-10D.) Our results 
show that treating isolated mitochondria from mouse gastrocnemius, with a 15% mixture 
of AA, increased rates of ADP stimulated oxygen consumption (state 3 JO) as well as 
improved the rate of ATP production (state 3 JP) (Figure 3-10). It is worth noting; treating 
isolated mitochondria with AA for 30 minutes on ice resulted in no significant changes in 
maximum ADP stimulated state 3 Jo. However, changes in state 3 Jo were observed after 
a time exceeding 90 minutes of 15% amino acid incubation.
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Figure 3-10. Representative oxygraph traces of mitochondrial respiration of isolated 
rodent mitochondria A) not treated (-AA) or B) treated (+AA) with amino acids obtained 
using an oxygraph respirometer (Hansatech Instruments, Norfolk, UK). Malate (M; 1 
mM) + pyruvate (P; 1 mM) + glutamate (G; 10 mM) were added and State 2 JO, State 2 
O2 consumption, was followed in both –AA and +AA SS mitochondria. State 3 JO was 
initiated with the addition of ADP (0.67 mM), and the maximal state 3 JO rate was 
measured in the – AA and  + AA. Following the phosphorylation of available ADP, -AA 
and +AA SS mitochondria returned to “resting state” and the state 4 JO, State 4 O2 
consumption, was followed for ADP/O and respiratory control ratio determinations. 
Average maximal state 3 Jo and state 3 Jp measurements associated with mitochondrial 
respiration in isolated SS mitochondria from mouse gastrocnemius (n=3) either C) not 
treated or D) treated with amino acids; SS mitochondria not treated with amino acids 
(SS1); SS mitochondria treated with amino acids (SS2); Data is presented as mean ± 
SEM. *P < 0.05). 
Figure Oxygen consumption of isolated subsarcolemmal (SS) mitochondria from mouse gastrocnemius either 
treated or not treated with 15% amino acids. Isolated SS mitochondria treated (B) with 15% amino acids (+AA) or not 
(A) treated with 15% amino acids (-AA). SS MITO were stimulated with 1 mM Malate (M) + 1 mM Pyruvate (P) + 10 
mM Glutamate (G) and respiration was followed (State 2 JO). State 3 JO was monitored following the addition of 62.5 
nmol of ADP. State 4 JO was monitored following the phosphorylation of the added ADP; (A)  Oxygen consumption 
from SS MITO following 90 min incubation without AA (control); (B) Oxygen consumption from SS MITO following 90 
min incubation with AA.
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“Resting” (states 2 and 4) JO, RCR and ADP/O in isolated SS mitochondria from mouse 
treated with amino acids 
 Both the state 2 JO and state 4 JO in isolated SS mitochondria from mouse 
gastrocnemius increased in response to the AA treatment (Figure 3-11A and B). However 
there were no significant differences in the ADP/O or RCR in response to the AA 
treatment in isolated mitochondria from mouse (Figure 3-11C and D).
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Figure 3-11. The state 2 Jo and State 4 Jo and functional indices of isolated SS 
mitochondria from mouse in response to amino acid treatment. A) State 2 JO and B) state 
4 JO of subsarcolemmal (SS) mitochondria either not treated (SS1) or treated (SS2) with 
amino acids.  State 2 JO was measured in the presence of Malate (1 mM) + Pyruvate (1 
mM) + Glutamate (10 mM) (MPG) as substrates. State 4 JO was measured following state 
3 JO after depletion of ADP (0.67 mM) in the medium. RCR and ADP/O of 
subsarcolemmal (SS) mitochondria either not treated (SS1) or treated (SS2) with amino 
acids were measured in the presence of MPG. The Data is presented as mean ± SEM; (*P 
< 0.05).
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Discussion 
 The current study examined the effects of elevated plasma AA concentration on 
skeletal muscle mitochondrial function in sedentary lean and obese adults. The main 
finding shows elevated plasma AA concentrations increase capacity of ATP production 
of SS mitochondria from muscle of lean participants but not obese subjects. Moreover, 
only the lean subjects showed increase in uncoupled respiration in response to elevation 
of plasma amino acids.  
 Current evidence suggest that elevation of plasma amino acids enhances the 
capacity of subsarcolemmal fraction of muscle mitochondria to produce ATP (Tatpati et 
al., 2010), and our results add further support to this evidence. Furthermore, whereas 
previous findings were limited to ATP production (Tatpati et al., 2010), we have 
measured mitochondrial respiration to more fully characterize mitochondrial function in 
skeletal muscle. In this regard, increased capacity for ATP production in the presence of 
elevated plasma amino acids in SS mitochondria in the lean subjects is supported by an 
increased state 3 Jo in this mitochondrial subpopulation.  
 Based on the mitochondrial substrates used, our results show that greater 
mitochondrial oxygen consumption in the SS mitochondria of the lean subjects when 
plasma amino acids increased was mediated by increased catalytic potential of both 
complex I (malate+pyruvate+glutamate as substrates) and complex II (succinate as 
substrate) of the mitochondrial electron transport chain. However, about 85% of muscle 
mitochondria are located in the interior of the cell proximal to the myofibrils, 
intermyofibrillar mitochondria (Hood, 2001). Because maximal mitochondrial oxygen 
consumption (and ATP production) did not improve in the IMF mitochondria under the 
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same conditions, our findings reveal a role of plasma amino acids in regulating 
specifically the SS compartment of the muscle mitochondrial reticulum. In this regard, 
we show that SS mitochondria in lean subjects are more responsive than IMF 
mitochondria in modifying their catalytic potential in response to increased plasma amino 
acids concentrations. 
 Reduced responsiveness of muscle SS mitochondria in the obese subjects to the 
elevated plasma AAs could have possibly resulted from reduced transport of plasma AAs 
into the muscle, secondary to reduced muscle AA transporters in the obese subjects. 
Although whether such a mechanism is implicated in the present findings remains to be 
determined, current evidence suggests that the content of skeletal muscle AA transporters 
does not differ between lean and obese subjects at basal or during elevated plasma AAs 
(Beals et al., 2016). On the other hand, lack of stimulation of mitochondrial maximal 
oxygen consumption by the plasma AAs in the obese subjects may be, at least in part, due 
to a trend for an already elevated respiratory capacity in these subjects at basal. 
Specifically, state 3 JO in SS mitochondria of the obese subjects during saline infusion 
was 94% of the AA-stimulated state 3 JO in SS mitochondria of the lean subjects. Our 
results, therefore, during saline infusion do not show mitochondrial dysfunction 
previously reported in obese subjects (Abdul-Ghani et al., 2009; Kelley et al., 2002), but 
are in agreement with other findings showing no differences in muscle mitochondrial 
function with obesity (Fisher-Wellman et al., 2014; Karakelides et al., 2010; Samjoo et 
al., 2013). In line with our findings in humans, basal state mitochondrial enzyme 
activities in rodents were 20-50% higher in the presence of increased muscle lipid 
availability (Turner et al., 2009), which is a typical observation in obese humans as well 
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(Malenfant et al., 2001). Current evidence suggests that mitochondria complexes in 
skeletal muscle in obese humans are exposed to relative greater amounts of redox 
cofactors (i.e., NADH) (Lefort et al., 2010). Therefore, it is possible that increased 
availability of mitochondrial substrate in the basal state in the muscle of the obese 
subjects provides a constant stimulus that increases the catalytic potential of 
mitochondrial electron transport chain complexes, thus minimizing the stimulation of 
these complexes by the increased plasma AA concentrations. 
 In addition to the utilization of protons to generate ATP via the ATP synthase 
complex, mitochondria also demonstrate proton leak (i.e., uncoupled respiration) across 
the mitochondrial inner membrane, running in parallel with the ATP synthesis. In this 
regard, measures of state 4 JO in isolated mitochondria indicate mainly proton leak 
(Nicholls, 1977). Previous reports have documented increased proton leak in response to 
fasting (Mollica et al., 2006) and acute exercise (Madsen, Ertbjerg, & Pedersen, 1996). In 
the present studies, state 4 JO increased (~ 75% with MPG) in response to the AA 
infusion in the SS mitochondria of the lean subjects only. Because state 4 JO did not 
change in IMF mitochondria, our results show that SS mitochondria have greater 
flexibility than IMF mitochondria to modify uncoupled respiration in response to acute 
increase in plasma AAs. It is noted that state 2 JO, which also reflects proton leak in the 
presence of reducing substrate(s) but absence of ADP (Makrecka-Kuka, Krumschnabel, 
& Gnaiger, 2015), and, therefore, is not affected by recycled ADP present during the state 
4 JO measurements, was also significantly higher in response to the increase in plasma 
AAs. To our knowledge, this study provides the first evidence showing that increased 
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plasma AA concentrations enhance uncoupled respiration in human skeletal muscle 
mitochondria. 
 Our finding related to state 4 JO show that acute elevation of plasma AAs induces 
“metabolic inefficiency” in the SS mitochondria of lean subjects. From a physiological 
perspective, this suggests increased capacity for fuel/energy utilization in SS 
mitochondria in the muscle of these subjects. It has been argued that such a response may 
have beneficial effects because it can limit the generation of reactive oxygen species due 
to excess nutrients (Liesa & Shirihai, 2013), and also prevent muscle nutrient overload 
observed in pathophysiological circumstances (Iossa et al., 2004). In line with our finding 
for increased uncoupled respiration at the mitochondrial level, AA infusion acutely 
increases whole body oxygen consumption and energy expenditure (Weissman et al., 
1983). Therefore, failure to increase uncoupled respiration in obese individuals in 
response to increased plasma AA concentrations (i.e., during the postprandial period) 
may impact the ability of these individuals to increase their overall energy expenditure 
and regulate body weight. 
 Because insulin alone stimulates mitochondrial ATP production (Stump et al., 
2003), enhanced mitochondrial function may be mediated by increased plasma insulin 
concentrations during the AA infusion. However, plasma insulin concentrations were not 
significantly higher when mitochondrial respiratory capacity increased during AA 
infusion compared to saline infusion in the lean subjects. Furthermore, insulin decreases 
proton leak (Nisr & Affourtit, 2014), which is opposite from what we observed in the 
lean subjects after AA infusion in the present study. Increased proton leak in the present 
study, therefore, would be the direct result of the increase in plasma AA concentrations, 
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and in the same manner that fatty acids alone increase mitochondrial uncoupling/proton 
leak (Tonkonogi, Krook, Walsh, & Sahlin, 2000). Using rodent muscle we found that 
treating isolated mitochondria with AAs increased mitochondrial respiration (Figure 3-
10). These findings, together with evidence for improved mitochondrial function in cell 
lines treated with the amino acid leucine (Sun & Zemel, 2009), indicate a possibly 
independent role of plasma AAs in enhancing mitochondrial function. In this regard, 
protein posttranslational modifications appear as a likely mechanism involved in the 
observed effects of plasma AAs on mitochondria. Future studies are warranted to 
examine the effects of AAs in modifying directly the activity of individual mitochondrial 
proteins.  
 A limitation of the present study is that complex II activity was evaluated without 
the presence of rotenone. This results in the formation of oxaloacetate that inhibits 
succinate dehydrogenase, and when compared to the experimental condition where 
succinate measurements are performed in the presence of rotenone (Gnaiger, 2014). 
However, we still found an increase in respiratory capacity (i.e., state 3 JO) under our 
experimental conditions in the lean but not obese subjects. It is possible that, as recent 
evidence indicates, robust respiration can be measured without rotenone at least up to a 
certain respiratory state (Bai, Fink, Yu, & Sivitz, 2016). Regardless, our overall findings, 
and when considering that the same effect of elevated plasma AAs on mitochondrial 
respiration was observed for Complex I activity, show stimulation of mitochondria 
function by plasma AA in lean but not obese humans.  
 In conclusion, our results describe specificity of plasma AAs in stimulating 
respiration of SS (but not IMF) mitochondria, and specifically enhancing uncoupled 
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respiration (i.e., state 4 JO) while sustaining increased capacity for ATP production (i.e., 
state 3 JO and JP). However, none of these effects of plasma AAs were observed in obese 
individuals. Reduced response of uncoupled respiration to increased plasma AA 
concentrations may play a role in attenuating overall energy expenditure in obese 
individuals.
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CHAPTER 4: PROTEOME DIFFERENCES IN SKELETAL MUSCLE 
MITOCHONDRIA BETWEEN LEAN AND OBESE HUMANS 
 
Abstract 
 Skeletal muscle is largely responsible for regulating whole-body energy 
metabolism. Mitochondrial dysfunction and dysregulation of energy metabolism is 
implicated in the etiology of obesity. We sought to investigate differences in the 
proteome of skeletal muscle mitochondria between lean and obese individuals. We 
hypothesized that obesity would result in a reduction in the abundance, as well as 
redistribution of mitochondrial proteins, within the mitochondrial reticulum, composed of 
subsarcolemmal (SS) and intermyofibrillar (IMF) mitochondria. We isolated SS and IMF 
mitochondrial fractions from vastus lateralis muscle biopsies using standard differential 
centrifugation techniques from sedentary lean (n=16; 9M/7F) and obese (n=17; 9M/8F) 
subjects (age: 33±3 vs. 31±2 years, mean±SE, P > 0.05; BMI: 23±1 vs. 34±1 kg/m2, P < 
0.05; Matsuda insulin-sensitivity index: 10.1±1.5 vs. 4.2±0.8, P < 0.05). Our study 
identified 674 and 550 mitochondrial specific proteins with at least two peptides in SS 
mitochondria and IMF mitochondria, respectively. The total abundance of normalized 
spectra in SS and IMF mitochondria was 2% and 9% lower, respectively, in muscle of 
obese subjects. We found 73 and 41 mitochondrial proteins from SS mitochondria and 
IMF mitochondria, respectively, exhibiting differential expression between the lean and 
obese subjects. Pathway analysis of the differentially expressed mitochondria proteins in 
SS and IMF mitochondria of obese by Kyoto encyclopedia of genes and genomes 
(KEGG) and REACTOME software revealed significant enrichment of the following 
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mitochondrial biological pathways (q < 0.01): citric acid cycle (TCA), electron transport 
chain (ETC), amino acid metabolism, and pyruvate metabolism. Additionally, the 
differentially expressed mitochondria proteins in IMF mitochondria obese subjects were 
associated with significant enrichment in mitochondrial biological pathways (P < 0.01) 
specific to IMF mitochondria from obese subjects including, metabolism of lipids, 
electron transport, and adenosine triphosphate (ATP) synthesis. Finally, our study shows 
the abundance of proteins associated with mitochondrial proton-motive force generation 
through NADH: ubiquinone oxidoreductase (complex I), in the cell periphery (i.e. SS 
mitochondria), is not different between lean and obese. However, the level of proteins 
assigned to ATP synthase (complex V), proteins that use mitochondrial proton-motive 
force for the phosphorylation of adenosine diphosphate (ADP), in the cell interior (i.e. 
IMF mitochondria), is lower in obese subjects. Overall our findings suggest obesity is 
associated with protein composition changes in SS and IMF mitochondria associated with 
key biological processes responsible for regulating energy metabolism in skeletal muscle. 
Introduction 
 Obesity is the underlying cause for diabetes, heart disease, cancer and impacts 
skeletal muscle mitochondrial function (K. Hojlund et al., 2010; Kim, Hickner, Cortright, 
Dohm, & Houmard, 2000; Toledo, 2014). Skeletal muscle mitochondria are unique with 
respect to their arrangement within myocytes, forming a continuous network or 
reticulum. Specifically, subsarcolemmal (SS) mitochondria are located near the 
periphery, while intermyofibrillar (IMF) are located near the myofibrils (Bakeeva, 
Chentsov YuS, & Skulachev, 1978; Glancy et al., 2015; Kayar, Hoppeler, Mermod, & 
Weibel, 1988; Kirkwood, Munn, & Brooks, 1986; T. Ogata & Yamasaki, 1997; Patel, 
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Glancy, & Balaban, 2016). Obesity results from an energy surplus. The excess energy is 
speculated to reside in the accumulation of lipid droplets within skeletal muscle (Gray, 
Tanner, Pories, MacDonald, & Houmard, 2003; Morino et al., 2005; V. B. Schrauwen-
Hinderling et al., 2007; Vera B Schrauwen-Hinderling, Hesselink, Schrauwen, & Kooi, 
2006; Toledo et al., 2008) and is associated with insulin resistance and impaired energy 
metabolism (Amati et al., 2011). Energy metabolism imbalance in muscle may in part be 
due to alterations within the mitochondria reticulum, in turn affecting the ability of 
myocytes to regulate the intracellular energy metabolism within skeletal muscle.  
 Recent evidence suggests the mitochondrial reticulum in skeletal muscle provides 
the pathway to transfer intracellular energy rapidly throughout the mitochondria network 
(Amchenkova, Bakeeva, Chentsov, Skulachev, & Zorov, 1988; Glancy et al., 2015; Patel 
et al., 2016). In other words, protein stoichiometry of SS mitochondria near the plasma 
membrane may play a critical role in the development of the proton-motive force, while 
the protein stoichiometry of the IMF mitochondria promotes the utilization of the proton-
motive force. Impaired mitochondria oxidative phosphorylation (OXPHOS) has been 
previously suggested to be due to abnormal phosphorylation at specific sites of enzymes 
involved in the catalysis of ATP production (K. Hojlund et al., 2010). In addition, studies 
have shown reduced content and functional capacities of muscle mitochondria (Kurt 
Hojlund et al., 2008; Kelley, He, Menshikova, & Ritov, 2002; Mogensen et al., 2007; 
Ritov et al., 2005) in obesity. The extent to which obesity alters the stoichiometry of 
proteins in SS mitochondria and IMF mitochondria in obesity requires further 
investigation. 
	 95 
 Preserving tightly-coupled bioenergetics functions in mitochondria isolated from 
skeletal muscle is possible (Cogswell, Stevens, & Hood, 1993; D. a. Hood, 1996; Kras et 
al., 2016; Palmer, Tandler, & Hoppel, 1977, 1985). However, the compartmentalized 
nature of mitochondria in skeletal muscle, SS mitochondria region and IMF mitochondria 
region, requires specialized fractionation techniques that make possible independent 
isolation of SS and IMF mitochondria. Studying SS and IMF mitochondria independently 
from muscle of lean and obese individuals may reveal differences in skeletal muscle 
mitochondria content with respect to location within the myocyte (i.e. SS or IMF 
mitochondria) along with differences in protein composition related to the capacity for 
energy distribution through out the myocyte at rest. Revealing the proteome of SS and 
IMF mitochondria between lean and obese individuals may provide insight into the 
following observations with respect to the proteins and pathways altered by obesity, 
specifically: 1) lower abundance of electron transport chain enzymes (Lefort et al., 2010); 
2) reduced ATP production (Abdul-Ghani et al., 2009; Jheng et al., 2012; Karakelides et 
al., 2010; Minet & Gaster, 2010); 3) reduced amino acid catabolism (Katsanos & 
Mandarino, 2011; Koves et al., 2008; Newgard et al., 2009); 4) reduced lipid oxidation 
(Boyle, Zheng, Anderson, Neufer, & Houmard, 2012; Kim et al., 2000); and 5) insulin 
resistance (De Filippis et al., 2008; Evans, Maddux, & Goldfine, 2005; Karakelides et al., 
2010). 
 Previous studies have focused on the global picture of changes in protein 
abundance in skeletal muscle in obesity by way of whole muscle tissue homogenates 
which are further separated by two-dimensional electrophoresis (Giebelstein et al., 2012; 
Théron et al., 2014). These approaches are laborious and costly. Other approaches, 
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involve fractionation of cellular components, such as mitochondrial proteins (Ferreira et 
al., 2010; K. Hojlund et al., 2010; Lefort et al., 2010; Ma et al., 2017). These studies are 
mostly based on two dimensional gel electrophoresis approach, with exception of Ma et 
al. (Ma et al., 2017), who used a Percoll gradient to purify the crude mitochondrial 
enriched pellet. They also used an “on-pellet-digestion” step. Similar to the approach we 
use in the current study. This approach has the advantage of being cost-effective, while 
simultaneously providing high-resolution in identification of peptides (León, 
Schwämmle, Jensen, & Sprenger, 2013; Rappsilber, Mann, & Ishihama, 2007). 
Moreover, in our hands this approach has permitted, for the first time, the investigation of 
the proteomes of sub populations of mitochondria within skeletal muscle from humans, 
linking differential expressions of proteins with pathways associated with regulating 
energy metabolism. 
 SS mitochondria seems particularly adapted to maintaining the energy charge 
needed for membrane-related processes, including signal transduction, ion exchange, 
substrate transport, and substrate activation (Cogswell et al., 1993; D. A. Hood, 2001). SS 
mitochondria and IMF mitochondria exhibit different bioenergetics properties and 
previous reports of impaired mitochondrial metabolism observed in muscle from obese 
could be specific to this population of mitochondria. SS mitochondria are likely more 
affected by obesity due to the ability of SS mitochondria to respond to metabolic changes 
compared to IMF mitochondria (Bizeau, Willis, & Hazel, 1998; D. a. Hood, 1996; Koves 
et al., 2005; Palmer et al., 1977, 1985; Ritov et al., 2005). Specifically, proteins of SS 
mitochondria are likely more affected by obesity compared to proteins of IMF 
mitochondria. To this point, the SS-to-IMF mitochondrial protein abundance ratios in 
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obese individuals as determined in the current study may account for the metabolic 
differences observed in obesity compared to healthy lean individuals. 
 The objective of this study was to perform label-free quantitative proteomics to 
identify proteins in isolated SS and IMF mitochondria fractions from muscle of obese and 
lean subjects. One of the major and novel findings from this study showed alterations in 
mitochondria protein composition in SS and IMF mitochondria during obesity. 
Specifically, the total abundance of mitochondria identified proteins in SS and IMF 
mitochondria was reduced in obese individuals relative to lean controls. We further 
showed that the proteins responsible for the reduced total abundance of mitochondrial 
proteins in SS and IMF mitochondria were primarily involved with the regulation of 
energy metabolism in muscle; electron transport and formation of ATP by chemiosmotic 
coupling. Our hypothesis, mitochondrial proteins known for using the proton-motive 
force would be reduced in IMF mitochondria from obese individuals, was supported by 
evidence of a reduced abundance of proteins assigned to electron transport and the 
enzyme complex ATP synthase. We further show evidence to support previous findings 
that skeletal muscle mitochondria from obese subjects have higher catalytic potential by 
our evidence of higher abundance of proteins involved in citric acid cycle. Overall, our 
data from this study shows that skeletal muscle mitochondria protein composition 
involved in key biological processes responsible for regulating energy metabolism in 
skeletal muscle is altered during obesity. 
Subjects and Methods 
Subjects 
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 Sixteen healthy sedentary lean and seventeen apparently healthy sedentary obese 
individuals participated in this study. Subject characteristics are reported in Table 1. The 
Institutional Review Board at Mayo Clinic approved the studies and all experimental 
procedures were performed in the Clinical Studies Infusion Unit (CSIU) at Mayo Clinic 
in Scottsdale, Arizona. Each participant was considered healthy based on medical history, 
routine physical examination, screening laboratory tests, metabolic panel, bioelectrical 
impedance analysis, and a two-hour oral glucose tolerance test (OGTT). The purpose, 
design, and the risks associated with this study were explained to each subject before 
obtaining written consent. Following a screening visit, all participants returned to the 
CSIU on a separate day for the main experiment that included collection of muscle 
biopsy. 
Experiment Design 
 Participants arrived at the CSIU at approximately 0630 h following an overnight 
fast. All subjects were instructed to refrain from any form of exercise for the 3-days prior 
to the study. A Bergström biopsy needled was used to collect percutaneous muscle 
biopsies (~100 mg) of the vastus lateralis under local anesthesia (lidocain, 2%). After 
removing blood, fat and visible connective tissues, the muscle biopsy was placed into a 
pre-massed beaker containing 2 ml of ice-cold Solution I (modified Chappell-Perry 
Medium I (Solution I; mM): 100 KCl, 40 Tris-HCl, 10 Tris-Base, 5 MgCl2, 1 EDTA, 1 
ATP, pH 7.5), reweighed, and the wet muscle mass was calculated. Average vastus 
lateralis muscle samples from lean and obese individuals collected were 107±9 mg (lean) 
vs. 122±12 mg (obese), respectively. 
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Methods 
Isolation of mitochondria 
 Isolated mitochondria from skeletal muscle of lean and obese individuals were 
prepared according to the outline in Figure 4-1; all procedures were carried out on ice or 
at 4°C and all centrifugations were 10 min in duration. Muscle biopsies were cleaned, 
weighed, minced with scissors in 9 volumes of ice-cold Solution I, and gently 
homogenized by hand using a ground glass-to-glass Potter-Elvehjem homogenizer (5 
passes). The homogenate was centrifuged at 800 x g to obtain the supernatant (SN 1) 
containing mechanically released subsarcolemmal mitochondria (SS mitochondria). The 
pellet from the initial 800 x g centrifugation, Potter-Elvehjem Pellet (PEP), containing 
intermyofibrillar mitochondria (IMF mitochondria), was subjected to 7-minute incubation 
with Nagarse, a bacterial enzyme protease. Nagarse (bacterial proteinase Type XXIV, 
Sigma, P-8038) was prepared using Solution I (5 mg.g-1 WW) and added to the PEP to 
liberate IMF mitochondria. After 7 min incubation, 1 ml of Solution I was added to the 
digested PEP, to slow enzymatic digestion. The resuspended PEP was then centrifuged at 
800 x g to separate the non-mitochondrial proteins and membranes from IMF 
mitochondria. The supernatant SN 2 containing IMF mitochondria was transferred to a 
new tube. The SN 1 containing SS mitochondria and the separate SN 2 containing IMF 
mitochondria were centrifuged at 14,000 x g to obtain two mitochondrial pellets, SS 
mitochondria and IMF mitochondria. After discarding the supernatant, each of the 
mitochondrial pellets were resuspended in 0.5 ml of Solution II (mM): 100 KCl, 40 Tris-
HCl, 10 Tris-Base, 5 MgCl2, 1 EDTA, 0.2 ATP, at pH 7.5. Following centrifugation at 
7000 x g, the supernatants were discarded and the mitochondrial pellets were 
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resuspended a third time in 0.5 ml of Solution II. After the final centrifugation at 4000 x 
g and removal of supernatant, the two final mitochondrial pellets (i.e. SS mitochondria 
and IMF mitochondria) were each resuspended in identical volumes of mannitol-sucrose 
buffer containing (mM) 220 Mannitol, 70 Sucrose, 10 Tris-HCl, 1 EGTA, pH 7.40.
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Figure 4-1. Isolation of skeletal muscle subsarcolemmal (SS) and intermyofibrillar (IMF) 
mitochondria from lean and obese individuals; SN - supernatant.
Figure 4-1. Schematic workflow showing strategies for isolation of skeletal muscle subsarcolemmal (SS) and intermyofibrillar 
(IMF) mitochondria and proteomics from lean and obese individuals; SN - supernatant. Quantification of proteins performed by 
spectra counting and normalization of spectral abundance.
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Centrifuge (800 X G)
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Homogenization Mitochondrial Isolation
Subsarcolemmal Mitochondria
Protein identifications accepted if they could be established at greater 
than 99.0% probability and contained at least 2 identified peptides;
(1449 Proteins - Supplemental Table S1a )
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
Proteomics
Proteome differences of subsarcolemmal mitochondria from human skeletal muscle
Gene Ontology Classified as 
Mitochondrial (GO:0005739)?
Missing total spectral count (TSC) replaced with 
lowest TSC within groups (i.e. Lean or Obese)
Lazar et al. Journal of Proteomics 2016
TSC adjusted by length of respective proteins, giving 
spectral abundance factor (SAF) 
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
SAF normalized, giving normalized 
spectral abundance factor (NSAF)
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010
Correct for batch effects witihin groups 
Keough M. Cambridge Univ. Press 2002; Gregori et al. Journal of Proteomics 2012; Quinn G.
Discoveries; Two-stage linear step-up procedure of Benjamini, 
Krieger and Yekutieli, with Q = 5%.
Assume all rows are from populations with the same scatter (SD).
Simes et al. Biometrika 1986; Gregori et al. Journal of Proteomics 2012; Lundby et al. Cell Reports 2012; Kulak et al. Nat. Methods 2014
Mitochondrial protein assigned with 99% confidence 
in >50% of subjects with ≥ 2 identif ed peptides?
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
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Supplemental Table S1b
NO; 775
No Further Analysis
YES; 539
Supplemental Table S1c
NO; 135
No Further Analysis
Significant by Unpaired TTest (P<0.05)
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Supplemental Table S1d
NO; 378
No Further Analysis
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Supplemental Table S1e
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No Further Analysis
Human Skeletal Muscle Biopsy
Lean (M/F; 7/9), Obese (M/F; 8/9)
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Citrate synthase activity 
 All citrate synthase assays carried out at 37º Celsius. Mitochondrial suspension 
was diluted 1:10 in mannitol sucrose buffer. This sample was then added to a cuvette 
containing (in mM) 0.025 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB), 0.125 acetyl-
CoA, and 0.05% Triton detergent in a final volume of 0.5 mL. The addition of 0.25 mM 
oxaloacetate initiated substrate-dependent activity and absorbance was followed at 412 
nm for three minutes to account for background activity. Activity was calculated using 
the millimolar extinction coefficient of 13.6 for the appearance of the mercaptide ion; 
formed when CoA is liberated during the citrate synthase reaction, reacting with DTNB. 
The degree of homogenization and the yield of mitochondria were estimated from citrate 
synthase activity assays carried out in aliquots of fractions from whole muscle 
homogenate described in Figure 4-1. Total citrate synthase activity was determined in the 
whole muscle homogenate (µmol.min-1). Total citrate synthase activity (µmol.min-1) was 
determined in 800xg (SN1) the Potter-Elvehjem pellet (PEP), the 800xg (SN2) and each 
of the final SS mitochondrial and IMF mitochondrial fractions. Fractions of total activity 
in SS mitochondria and IMF mitochondria fractions versus the total citrate synthase 
recovered from either SN1, SN2 represent the mitochondrial yield (Fractional Yield %). 
The protein content in the final mitochondrial preparations was determined by the method 
of Lowry (Lowry, Rosebrough, Farr, & Randall, 1951). 
In-solution digest of mitochondrial proteins 
 Skeletal muscle mitochondria proteomics analyses were performed using an in-
solution digest protocol as previously described (Kras et al., 2016). In brief; A volume of 
isolated SS mitochondria or IMF mitochondria preparation, was added to a 9 times 
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volume of dilution buffer [DB; 10% acetonitrile (ACN) and 25mM Tris–HCl pH 8.5]. 8 
µl trypsin (Sigma; St. Louis, MO) at 0.200 µg/ml was added to the protein sample and 
was allowed to incubate for 16 h at 37 °C with gentle shaking, followed by addition of 50 
µl 5% formic acid (FA) to halt the digestion. The resulting peptides were prepared for 
sample analysis similar to a previously published protocol (Kulak, Pichler, Paron, 
Nagaraj, & Mann, 2014). In brief, a stop-and-go extraction tip (StageTip) (Rappsilber et 
al., 2007), was fitted with two C18 disk plugs using a customized tipping syringe 
(Rappsilber et al., 2007). The Stage Tip was activated with methanol, washed in 100 µl 
buffer B (0.1% FA, 80% ACN), and equilibrated in 100 µl buffer A (0.1% FA) twice. 
The peptides were then loaded onto the activated Stage Tip, washed twice in 100 µl 
buffer A, followed by elution in 50 µl Buffer B. The eluate was dried by vacuum 
centrifugation and stored at -80 °C prior to use. 6 µl of 0.1% FA (v/v) was added to re-
suspend the dried samples, followed by sonication for 2 min. The sonicated samples were 
briefly centrifuged and 1 µl of sample was subsequently analyzed by mass spectrometry 
as described below. 
Mass spectrometry 
 HPLC-ESI-MS/MS was performed on a Thermo Electron Orbi-trap Elite Velos 
Pro fitted with an EASY source (Thermo Electron, San Jose, CA). NanoLC was 
performed using a DIONEX/Thermo NCS-3500RS UltiMate 3000 with an EASY Spray 
column (Thermo Electron, 50 cm x 75-mm inner diameter, packed with PepMap RSLC 
C18 material, 2 µm); loading phase for 15 min; mobile phase, linear gradient of 1–37% 
ACN in 0.1% FA in 150 min, followed by a step to 95% ACN in 0.1% FA over 5 min, 
hold 10 min, and then a step to 1% ACN in 0.1% FA over 1 min and a final hold for 19 
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min (total run 200 min); Buffer A = 0.1% FA in 100% H2O; Buffer B = 0.1% FA in 
100% ACN; flow rate, 300 nl/min. All solvents were mass spectrometry grade. A “top 
15″ data-dependent MS/MS analysis was performed (acquisition of a full scan spectrum 
followed by collision-induced dissociation mass spectra of the 15 most abundant ions in 
the survey scan).  
Database Searching 
 Tandem mass spectra were extracted by msconvert version 3 using default 
settings. Charge state deconvolution and deisotoping were not performed. The fragment 
mass spectra were then searched against the human SwissProt_2017_01 database, using 
Mascot (Matrix Science, London, United Kingdom; version 2.4) and X! Tandem. Cross- 
correlation of Mascot search results with X! Tandem was accomplished with Scaffold 
(version Scaffold_4.6.1; Proteome Software, Portland, OR). Probability assessment of 
peptide assignments and protein identifications were made through the use of Scaffold. 
Only peptides with > 95%probability were considered. The assumption was set for the 
digestion enzyme strict trypsin. X! Tandem was set up to search the 2017_Jan_human 
database (SwissProt_2017_01, 313776 entries) also assuming strict trypsin. Mascot and 
X! Tandem were searched with a fragment ion mass tolerance of 0.60 Da and a parent ion 
tolerance of 10.0 PPM. Glu->pyro-Glu of the n-terminus, ammonia-loss of the n-
terminus, gln->pyro-Glu of the n-terminus, oxidation of methionine and 
carbamidomethyl of cysteine were specified in X! Tandem as variable modifications. 
Oxidation of methionine and carbamidomethyl of cysteine were specified in Mascot as 
variable modifications.  
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Criteria for Protein Identification 
 Scaffold (version Scaffold_4.6.1, Proteome Software Inc., Portland, OR) was 
used to validate MS/MS based peptide and protein identifications. Peptide identifications 
were accepted if they could be established at greater than 95.0% probability by the 
Scaffold Local FDR algorithm. Protein identifications were accepted if they could be 
established at greater than 95.0% probability and contained at least 2 identified peptides.  
Protein Prophet algorithm assigned all protein probabilities (Nesvizhskii, Keller, Kolker, 
& Aebersold, 2003). Proteins that contained similar peptides and could not be 
differentiated based on MS/MS analysis alone were grouped to satisfy the principles of 
parsimony. Proteins sharing significant peptide evidence were grouped into clusters. 
Area-proportional Venn diagrams were drawn by using free software available from 
BioinfoRX; (http://apps.bioinforx.com/). 
Protein Quantitation for Comparative Proteomics 
 Samples used in the comparative proteomics experiments presented in this work 
were normalized total spectral count (TSC). Proteins identified as mitochondrial by gene 
ontology (GO:0005739) were used for final analysis. Briefly, Gene ontology (GO) 
describes function with respect to three aspects: molecular function (molecular-level 
activities performed by gene products), cellular component (the locations relative to cellular 
structures in which a gene product performs a function), and biological process (the larger 
processes, or ‘biological programs’ accomplished by multiple molecular activities) (Gene et 
al., 2011; Gene & Consortium, 2017). Missing TSC values across each of the identified 
proteins were replaced by the lowest reported TSC within each of the groups (i.e. lean or 
obese) (Lazar, Gatto, Ferro, Bruley, & Burger, 2016). TSC were used to determine the 
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normalized spectral abundance factors (NSAF) for protein abundance across samples as 
previously described (Hwang et al., 2010; Lefort et al., 2009); TSC were normalized to 
the length of respective identified protein. The sum of the normalized TSC (spectral 
abundance factor; SAF) was applied to SAF within the sample to generate the normalized 
spectral abundance factor (NSAF). We observed confounding clustering of samples run 
on different days. Therefore samples were batch mean centered (Gregori et al., 2012) to 
correct for this observed batch effect. In brief, each of the determined NSAF values was 
shifted by the mean of the identified protein within each group, to center the NSAF 
values to the mean. Means for the identified proteins, adjusted to zero, were shifted to the 
median NSAF values. A few proteins had negative values and they were corrected by 
shifting the whole row to a minimum value of 0 spectral count by subtracting the 
minimum NSAF across all samples, which resulted in samples corrected for variances 
observed due to batch effects. The batch corrected NSAF values were then used for the 
final analysis and discovery was determined using the two-stage linear step-up procedure 
of Benjamini, Krieger and Yekutieli; FDR < 0.05 (Benjamini, Krieger, & Yekutieli, 
2006). 
 There were a large number of proteins assigned in at least one of the 33 subjects. 
Therefore only proteins detected in ≥ 17 of the 33 subjects were used for statistical 
comparisons (K. Hojlund et al., 2010; Hwang et al., 2010; Xie et al., 2016). Gene 
Ontology (GO) annotation was performed using the Database for Annotation, Visualization 
and Integrated Discovery (DAVID) Bioinformatics Resources v6.7 (http://david.abcc. 
ncifcrf.gov) (Huang, Sherman, & Lempicki, 2009). Protein identifications assigned to 
mitochondria by GO:0005739, detected in >50% of subjects, were used in the downstream 
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final analysis to determine differentially expressed proteins in SS mitochondria and IMF 
mitochondria between lean and obese subjects. Figure 4-2 and Figure 4-3 detail the workflow 
to determine differences in the proteome of SS mitochondria and IMF mitochondria, 
respectively, between lean and obese individuals. Normalized spectral abundance factors 
were mean scaled to 1 for lean when analyzing abundance of normalized spectra from 
manually curated sets of proteins between lean and obese subjects.
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Figure 4-2. Workflow showing the steps for protein quantitation and comparative 
proteomics in skeletal muscle subsarcolemmal (SS) mitochondria. Appendix A provides 
mitochondria protein identifications as indicated in the workflow.
Homogenization Mitochondrial Isolation
Subsarcolemmal Mitochondria
Protein identifications accepted if they could be established at greater 
than 99.0% probability and contained at least 2 identified peptides;
(1449 Proteins)
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
Proteomics
Gene Ontology Classified as 
Mitochondrial (GO:0005739)?
Missing total spectral count (TSC) replaced with 
lowest TSC within groups (i.e. Lean or Obese)
Lazar et al. Journal of Proteomics 2016
TSC adjusted by length of respective proteins, giving 
spectral abundance factor (SAF) 
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
SAF normalized, giving normalized 
spectral abundance factor (NSAF)
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010
Correct for batch effects witihin groups 
Gregori et al. Journal of Proteomics 2012
Discoveries; Two-stage linear step-up procedure of Benjamini, 
Krieger and Yekutieli, with Q ≤ 5%.
Simes et al. Biometrika 1986; Gregori et al. Journal of Proteomics 2012; Lundby et al. Cell Reports 2012; Kulak et al. Nat. Methods 2014
Mitochondrial protein assigned with 99% 
confidence in >50% of subjects?
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
YES; 674 NO; 775
No Further Analysis
YES; 539
Appendix A
NO; 135
No Further Analysis
Significant by Unpaired TTest (P<0.05)
YES; 161
Appendix A
NO; 378
No Further Analysis
YES; 73
Appendix A
NO; 88
No Further Analysis
Human Skeletal Muscle Biopsy
Lean (M/F; 7/9), Obese (M/F; 8/9)
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Figure 4-3. Workflow showing the steps for protein quantitation and comparative 
proteomics in skeletal muscle intermyofibrillar (IMF) mitochondria. Appendix B 
provides mitochondria protein identifications as indicated in the workflow schematic.  
Homogenization Mitochondrial Isolation
Intermyofibrillar Mitochondria
Protein identifications accepted if they could be established at greater 
than 99.0% probability and contained at least 2 identified peptides;
(1016 Proteins)
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
Proteomics
Gene Ontology Classified as 
Mitochondrial (GO:0005739)?
Missing total spectral count (TSC) replaced with 
lowest TSC within groups (i.e. Lean or Obese)
Lazar et al. Journal of Proteomics 2016
TSC adjusted by length of respective proteins, giving 
spectral abundance factor (SAF) 
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
SAF normalized, giving normalized 
spectral abundance factor (NSAF)
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010
Correct for batch effects witihin groups 
Gregori et al. Journal of Proteomics 2012
Mitochondrial protein assigned with 99% 
confidence in >50% of subjects?
Hwang et al. Diabetes 2010; Lefort et al. Diabetes 2010; Caruso et al. Diabetes 2014
YES; 550 NO; 466
No Further Analysis
YES; 301
Appendix B
NO; 249
No Further Analysis
Significant by Unpaired TTest (P<0.05)
YES; 74
Appendix B
NO; 227
No Further Analysis
YES; 41
Appendix B
NO; 33
No Further Analysis
Human Skeletal Muscle Biopsy
Lean (M/F; 7/9), Obese (M/F; 8/9)
Discoveries; Two-stage linear step-up procedure of Benjamini, 
Krieger and Yekutieli, with Q ≤ 5%.
Simes et al. Biometrika 1986; Gregori et al. Journal of Proteomics 2012; Lundby et al. Cell Reports 2012; Kulak et al. Nat. Methods 2014
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Principal component, heatmap analysis, and functional annotations for mitochondria protein 
identifications in SS and IMF mitochondria 
 Heatmaps, hierarchical clustering, and Principal Component Analysis (PCA) was 
performed using ClustVis (http://biit.cs.ut.ee/clustvis/) (Metsalu & Vilo, 2015). The STRING 
10.5 database (Search Tool for the Retrieval of Interacting Genes/Proteins) was used to 
determine functional associations between differentially expressed proteins between lean and 
obese. Pathway analysis was also performed using STRING version 10.5 database 
(http://string-db.org), STRING analysis options were based on “evidence” mode, 
disconnected nodes were hidden, we did not add or remove any protein partners (Szklarczyk 
et al., 2015). More comprehensive pathway enrichment analysis was performed using Kyoto 
Encyclopedia of Genes and Genome (KEGG) (H. Ogata et al., 1999) and REACTOME 
software (Fabregat et al., 2016; Milacic et al., 2012). 
Statistical Analysis 
 Data are presented as means ± SEM. Unpaired; parametric two-tailed t tests were 
used to determine which identified proteins were differentially expressed between lean 
and obese groups (P < 0.05). Significant differentially expressed proteins (DEP) between 
lean and obese were then further scrutinized and discovery determination was based on a 
false discovery rate (FDR) (p  < 0.10) (GraphPad Prism7); Statistical significance was set at 
P ≤ 0.05. Analyses performed using statistical software (GraphPad Prism7 Software, San 
Diego, CA). 
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Results 
 Physical and metabolic characteristics for study participants with (n = 17; BMI > 30 
kg/m2) and without (n=16) obesity are shown in Table 4-1. The obese subjects had 
significantly higher BMI, fat mass, fasting plasma insulin, and HbA1c, compared to lean 
controls. However, systolic and diastolic blood pressures, fasting blood glucose levels, 
plasma non-esterified fatty acids (NEFA), as well as total plasma cholesterol were 
comparable to the lean subjects, indicative of a relatively healthy group of obese individuals 
with similar age and gender distribution.
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Table 4-1. Characteristics of the study participants (n=33) classified as either lean or 
obese. 
 Lean Obese pValue 
n (F/M) 16(7/9) 17(8/9)   
Age (Years) 33.0±2.5 
 
31.5±2.5 
 
0.667 
Weight (kg) 68.5±2.6 98.5±3.5 <0.001 
Height (cm) 170.9±1.9 170.6±2.4 0.924 
BMI (kg.m-2) 23.3±0.6 34.2±0.8 <0.001 
FFM (kg) 49.8±3.1 64.8±2.8 <0.01 
FM (kg) 10.8±1.0 21.7±1.0 <0.001 
Body fat mass (%) 22.5±2.2 34.2±1.6 <0.001 
VO2max (ml.min-1) 2086±164 2286±134 0.350 
VO2max (ml.kgFFM-1.min-1) 30.4±1.9 23.6±1.4 <0.01 
Waist circumference (cm) 80.1±1.9 106.7±3.2 <0.001 
Hip circumference (cm) 98.1±1.8 118.1±2.6 <0.001 
Waist-to-hip ratio 0.82±0.01 0.91±.03 <0.01 
Systolic blood pressure (mmHg) 127±6 121±3 0.461 
Diastolic blood pressure (mmHg) 73±2 76.2±2 0.368 
Fasting blood glucose (mg.dL-1) 87.4±1.6 91.4±3.5 0.310 
Fasting plasma insulin (µIU.ml-1) 5.0±0.8 11.1±1.2 <0.001 
Matsuda-ISI 10.1±1.5 4.2±0.8 <0.01 
HOMA-IR 1.1±0.2 2.6±0.3 <0.01 
HbA1C (%) 5.2±0.1 5.5±0.1 <0.05 
Plasma triglycerides (mg.dL-1) 86.6±13.7 133.1±20.5 0.069 
Plasma NEFA (mmol.L-1) 0.34±0.05 0.39±0.04 0.347 
Total plasma cholesterol (mg.dL-1) 170.9±9.4 177.3±6.5 0.579 
Plasma HDL-Cholesterol (mg.dL-1) 61.3±3.9 46.5±2.9 <0.01 
Plasma LDL-Cholesterol (mg.dL-1) 92.3±7.8 104.3±6.3 0.242 
TSH (mIU.L-1) 2.1±0.4 2.4±0.3 0.509 
Table 4-1 Baseline subject characteristics values are presented as mean ± SEM; BMI, 
body mass index, FFM, fat free mass, Matsuda Index, indices of sensitivity to insulin, 
Homeostatic model assessment, assess β-cell function and insulin resistance (IR), HbA1c, 
fraction of glycated hemoglobin, TSH, thyroid stimulating hormone. Significance 
determined by unpaired t test; P < 0.05.
	 113 
Proteome analysis of skeletal muscle mitochondria 
 
 A total of 1,449 proteins were assigned in ≥ 1 of the 33 subjects from the 
subsarcolemmal mitochondrial fractions, while a total of 1,016 proteins were assigned in ≥ 1 
of the 33 subjects from the intermyofibrillar mitochondrial fractions. 674 identified proteins 
were assigned to mitochondria by gene ontology (GO) in SS mitochondria and 550 identified 
proteins were assigned to mitochondria by GO in IMF mitochondria. Among the 674 SS and 
501 IMF mitochondria protein identifications, 539 and 301 were detected in ≥ 17 subjects in 
SS and IMF mitochondria, respectively (Appendix A, Appendix B). Area-proportional 
Venn diagrams show numbers of protein identifications and overlap of data sets from either 
SS or IMF mitochondria (Figure 4-4). 
	 114 
 
Figure 4-4. Area proportional Venn diagrams showing protein identifications, 
overlapping identifications in subsarcolemmal or intermyofibrillar mitochondria from 
lean and obese (n≥17) revealed by proteomics; A) 556 proteins from subsarcolemmal 
mitochondrial fraction detected in ≥1 subjects, 893 proteins overlap and detected in both 
subsarcolemmal and intermyofibrillar mitochondrial fractions in ≥1 subjects, and 123 
intermyofibrillar mitochondria proteins detected in ≥1 subjects; B) 249 proteins assigned 
to mitochondria by gene ontology (GO: 0005739), in subsarcolemmal mitochondria 
detected in >50% of all subjects, 290 proteins assigned to mitochondria that overlap both 
subsarcolemmal mitochondria and intermyofibrillar mitochondria in >50% of all 
subjects, and 11 proteins assigned to mitochondria from intermyofibrillar mitochondria 
detected in >50% of all subjects. 
249 290
Figure 2. Area proportional Venn diagrams showing protein identifications, overlapping identifications 
in subsarcolemmal or intermyofibrillar mitochondria from l a  and obe e (n≥17); A) 556 proteins from 
subsarcolemmal (SS) mitochondrial fractions detected in ≥1 subjects, 893 proteins overlap and detected in 
both SS and intermyofibrillar (IMF) mitochondrial fractions in ≥1 subjects, and 123 IMF MITO proteins detected 
in ≥1 subjects; B) 249 proteins assigned to mitochondria by gene ontology (GO: 0005739), in SS mitochondria 
detected in >50% of all subjects, 290 proteins assigned to mitochondria that overlap both SS mitochondria and 
IMF mitochondria in >50% of all subjects, and 11 protein  assigned to itochondria from IMF mitochondria 
detected in >50% of all subjects.
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Total normalized spectral abundance in either SS or IMF mitochondria between lean and 
obese 
 Comparing the total abundance of normalized spectra from either the 539 or 301 
mitochondria protein identifications in either SS or IMF mitochondria between the lean and 
obese groups revealed the following: total abundance of normalized spectra (∑NSAF) from 
539 mitochondria proteins in SS mitochondria was reduced by 2 % in obese subjects 
compared to lean controls (Figure 4-5A); (493.1 ± 1.9, (n=17) vs. 500.7 ± 1.7, (n=16)); P = 
0.0046); the ∑NSAF from 301 mitochondria proteins in IMF mitochondria was reduced by 
9% in obese subjects compared to lean controls (Figure 4-5B); (548.5 ± 10.58, (n=17) vs. 
604.2 ± 6.385, (n=16)); P = 0.0001.
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Figure 4-5. Total abundance of normalized spectral abundance factors (∑NSAF) from 
539 and 301 mitochondrial protein identifications measured in subsarcolemmal (SS) and 
intermyofibrillar (IMF) mitochondria, respectively in lean and obese subjects. The 
∑NSAF of 539 mitochondria protein identifications in A) SS mitochondria was 2% lower 
in obese compared to lean controls while the ∑NSAF from 301 mitochondria protein 
identifications in B) IMF mitochondria was 9 % lower in the obese group, compared to 
lean controls; ∑NSAF = sum of determined normalized spectral abundance factor 
(NSAF) for each of the 539 and 301 mitochondria protein identifications in SS and IMF 
mitochondria respectively, shown in Figure 4-4B; Data presented are ∑NSAF X 1000 ± 
SEM; Statistical significance determined by parametric Unpaired t test; (**, P < 0.01, 
***, P < 0.001). 
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Total abundance of normalized spectra in SS and IMF mitochondria between lean and obese 
involved with regulation of energy metabolism 
 To determine which sets of proteins might be responsible for the significantly reduced 
abundance of normalized spectra in SS and IMF mitochondria of obese, we investigated 
manually curated protein sets assigned to key biological processes involved with regulation 
of energy metabolism in skeletal muscle. One well-established key biological process in 
mitochondria associated with energy metabolism is oxidation-reduction process 
(GO:0055114). Therefore, we sought to investigate differences in total abundance of 
normalized spectra assigned to the key biological process of oxidation-reduction, which 
includes proteins involved in the citric acid cycle (TCA), the respiratory electron transport 
chain and ATP synthase. We hypothesized that SS and IMF mitochondria from obese would 
have a lower total abundance of normalized spectra (ΣNSAF) assigned to TCA, ETC and 
ATP synthase compared to lean controls, based on the results in Figure 4-5 showing a 
reduced total abundance of normalized spectra in SS and IMF mitochondria from obese. 
However, the ΣNSAF assigned to TCA, ETC and ATP synthase was not different in SS 
mitochondria between groups (Figure 4-6A). Furthermore, the ΣNSAF assigned to TCA and 
succinate-coenzyme Q reductase (complex II) were significantly higher in IMF mitochondria 
of obese compared to lean controls, while the ΣNSAF for NADH: ubiquinone oxidoreductase 
(complex I), cytochrome c – oxidoreductase (complex III), and ATP synthase (complex V) 
were all significantly reduced in IMF mitochondria of obese (Figure 4-6B).
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Figure 4-6. Mean scaled total abundance of normalized spectra (ΣNSAF) for manually 
curated protein sets assigned to citric acid cycle (TCA), electron transport chain 
complexes I - IV (ETC), and ATP synthase (complex V) from skeletal muscle 
mitochondria between lean and obese individuals; mean scaled ΣNSAF for TCA, ETC 
and complex V from A) SS and B) IMF mitochondria between lean and obese; ΣNSAF = 
sum of normalized spectral abundance factors (NSAF) for each of the mitochondria 
protein identifications associated with complex I – V, and TCA. Mean scaled ΣNSAF 
adjusted to 1 for the lean. Data is presented as mean scaled ΣNSAF ± SEM; Statistical 
significance determined using Unpaired, parametric t test within each pathway; (*, P < 
0.05; **, P < 0.01)
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Ratios of normalized spectra assigned to citric acid cycle versus electron transport and ATP 
synthase between lean and obese 
 With evidence showing an increased total abundance of normalized spectra assigned 
to TCA along with an overall reduced abundance of normalized spectra assigned to electron 
transport chain and ATP synthase in IMF mitochondria of obese (Figure 4-6B), we wanted to 
investigate the relative abundance of mitochondria protein identifications assigned to TCA 
versus ETC plus ATP synthase in both SS and IMF mitochondria between lean and obese 
subjects. As expected there was no difference in the ratio for total abundance of normalized 
spectra assigned to TCA versus ETC plus ATP synthase in SS mitochondria between groups 
(Figure 4-7A). However there was a significantly higher ratio for total abundance of 
normalized spectra assigned to TCA versus ETC plus ATP synthase in IMF mitochondria 
between groups (Figure 4-7B) (P < 0.05).
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Figure 4-7. Mean scaled total abundance of normalized spectra (∑NSAF) ratios for 
manually curated protein sets assigned to citric acid cycle (TCA) versus the electron 
transport chain complexes I - IV (ETC), and ATP synthase (complex V) from skeletal 
muscle mitochondria between lean and obese individuals; mean scaled ∑NSAF ratio for 
TCA versus ETC + complex V from A) SS and B) IMF mitochondria between lean and 
obese; ∑NSAF = sum of normalized spectral abundance factors (NSAF) for each of the 
mitochondria protein identifications associated with manually curated protein sets of 
interests, within each subject (n ≥ 30) sampled. Data is presented as mean scaled ∑NSAF 
ratio ± SEM; Statistical significance determined using Unpaired, parametric t test; (**, P 
< 0.01).
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A total of 73 and 41 differentially expressed protein identifications in SS and IMF 
mitochondria between lean and obese individuals 
 Among 539 and 301protein identifications in SS and IMF mitochondria, 
respectively, 73 and 41 were significantly different between lean and obese subjects as 
determined by Unpaired parametric t test (P < 0.05) and passing false discovery rate 
(FDR) criteria (P < 0.1) with a FDR cutoff P ≤ 0.05. Following identification of the 73 
and 41 differentially expressed proteins (DEP) in SS and IMF mitochondria, respectively, 
between lean and obese, REACTOME analyses were performed on these proteins with 
respect to the direction of their expression to reveal significant pathway assignments. 
Specifically, Uniprot identifications of the DEPs in SS and IMF mitochondria were 
mapped to pathways and over-representation analysis was performed using REACTOME 
software. REACTOME pathways were over-represented (enriched) in the submitted 
protein identifications.  
Among the 73 DEPs in SS mitochondria from obese, 28 and 45 were up- and down-
regulated, respectively (Appendix A).  Significantly enriched pathways (i.e. pathways that 
were over-represented in the differentially expressed proteins in SS mitochondria) are 
reported as the –log transformed false discovery rate p value (i.e. –log (p Value)). The most 
significant pathways enriched in DEP in SS mitochondria of obese subjects relative to lean 
controls are shown in Figure 4-8A, and included: the citric acid cycle (TCA) and respiratory 
electron transport (P < 0.0001); respiratory electron transport, ATP synthesis by 
chemiosmotic coupling, and heat production by uncoupling proteins (P < 0.0001); 
mitochondrial protein import (P < 0.0001); mitochondrial translation (P < 0.0001); complex 
I biogenesis (P < 0.0001); and metabolism of amino acids and derivatives (P < 0.001). 
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REACTOME analysis in submitted DEP in SS mitochondria of obese subjects is presented in 
Appendix C.  
 Among the 41 DEPs in IMF mitochondria from obese, 13 and 28 were up and down-
regulated, respectively (APPENDIX B). The most significant pathways that were over-
represented in DEP in IMF mitochondria of obese subjects relative to lean controls are shown 
in Figure 4-8B including: the citric acid (TCA) cycle and respiratory electron transport (P < 
0.0001); formation of ATP by chemiosmotic coupling (P < 0.0001); complex I biogenesis (P 
< 0.0001); mitochondrial protein import (P < 0.0001); and Fatty acid metabolism (P < 
0.001). REACTOME analysis in submitted DEP in IMF mitochondria of obese subjects is 
presented in Appendix D. 
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Figure 4-8. Pathways associated with the differentially expressed proteins in SS and IMF 
mitochondria between lean and obese individuals. Significant pathways of differentially 
expressed proteins (DEPs) in A) SS and B) IMF mitochondria between lean and obese 
individuals based on the REACTOME database analysis. The total numbers of 
differentially expressed proteins for a given pathway are given in parentheses. Tables 
showing REACTOME analysis in submitted DEPs in SS and IMF mitochondria between 
lean and obese individuals appear in Appendices C and D, respectively.
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Proteins involved in mitochondrial energy metabolism are differentially expressed in SS 
and IMF mitochondria between lean and obese individuals 
 Based on REACTOME pathway analysis, the majority of the differentially 
expressed proteins in SS and IMF mitochondria between lean and obese were associated 
with the citric acid cycle and electron transport (Figure 4-8A and B). The analysis of the 
subsets of differentially expressed proteins in SS and IMF mitochondria of obese, 
assigned to pathways based on REACTOME in Figure 4-8, revealed the that in total there 
were 12 and 29 differentially expressed mitochondria proteins that were up- and down-
regulated in SS mitochondria, respectively, in obese relative to lean controls. Meanwhile 
there were 12 and 16 differentially expressed mitochondria proteins that were up- and 
down-regulated in IMF mitochondria, respectively, in obese compared to lean controls 
(Figure 4-9). 
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Figure 4-9. A subset of differentially expressed proteins located in SS and IMF 
mitochondria participating in pathways associated with mitochondria energy metabolism. 
The log2 fold change of differentially expressed proteins (DEPs) in A) SS and B) IMF 
mitochondria of obese relative to lean controls. The green and red bars represent up and 
down-regulated proteins, respectively, in obese relative to lean controls. Functional 
annotations assigned to protein groups were REACTOME based. REACTOME analyses 
of DEPs are located in Appendices C and D.
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Protein-protein interactions of differentially expressed proteins in SS and IMF 
mitochondria of obese individuals 
 Using a more comprehensive protein-protein interaction network database, STRING, 
we detected 56 protein-protein interaction networks, based on key biological processes by 
gene ontology, in SS mitochondria enriched with ≥ 5 of the 73 significantly differentially 
expressed proteins (P < 0.05) including: respiratory electron transport chain (ETC) (P < 
0.0001); cellular amino acid catabolic process (P < 0.0001); oxidative phosphorylation 
(OXPHOS) (P < 0.0001); mitochondrial translational initiation (P < 0.0001); 
mitochondrial electron transport, NADH to ubiquinone (P < 0.0001); mitochondrial 
translation (P < 0.0001); mitochondrial ATP synthesis coupled electron transport (P < 
0.0001); and tricarboxylic acid cycle (TCA) (P < 0.0001) (Appendix E). 
 Among the 41 DEPs in IMF mitochondria in obese, using STRING, we detected 24 
protein-protein interaction networks, also based on key biological processes by gene 
ontology, in IMF mitochondria enriched with ≥ 5 differentially expressed assigned 
proteins (P < 0.05) including: respiratory electron transport chain (P < 0.0001); 
mitochondrial electron transport, NADH to ubiquinone (P < 0.0001); mitochondrial ATP 
synthesis coupled electron transport (P < 0.0001); and oxidative phosphorylation (P < 
0.0001) (Appendix F). 
	 127 
Differentially expressed proteins in SS mitochondria and IMF mitochondria from obese 
individuals organize into distinguishable clusters 
 Principal component analysis (PCA) was performed on the expression levels for the 
73 DEPs in SS mitochondria of obese (up-regulated ≥ 1.43 or down-regulated ≤ 0.68; P ≤ 
0.05); (Appendix A) and 41 DEPs in IMF mitochondria of obese (up-regulated ≥ 1.46 or 
down-regulated ≤ 0.71; P ≤ 0.05); (Appendix B). Separate principal component analyses 
(PCA) of the 73 and 41 differentially expressed proteins (DEP), indicated above, in either 
SS or IMF mitochondria, revealed that difference in relative fold changes in DEP from 
obese relative to lean, were sufficient to differentiate each of the groups from the others; 
(Figure 4-10A) (Figure 4-11A). We compared the 73 DEP in SS mitochondria as well as 
the 41 DEP in IMF mitochondria from obese and results are presented as heatmaps 
(Figure 4-10B) and (Figure 4-11B). Rows of heatmaps were centered and unit variance 
scaling was applied. Both rows and columns were clustered using correlation distance 
and average linkage. Hierarchical clustering analysis of DEP in either SS or IMF 
mitochondria organized into distinguishable clusters; up (Green bar) and down-regulated 
(Red bar) DEP in SS and IMF mitochondria of obese relative to lean controls. 
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Figure 4-10. Principal component analysis and heatmaps for differentially expressed 
mitochondrial protein identifications in human skeletal muscle subsarcolemmal 
mitochondria. A) Principal component analysis (PCA) and B) heatmap of 73 
differentially expressed proteins in subsarcolemmal mitochondria; up-regulated (Green) 
and down-regulated (Red) differentially expressed proteins in subsarcolemmal 
mitochondria of obese relative to lean. Columns represent each subject in the study. 
Columns 1 - 16 = lean controls; columns 17 – 33 = obese subjects.  
A
B
Figure . Proteome dynamics in human skeletal muscle mitochondria. Principal component analysis (PCA) of A) 69 
differentially expressed proteins (DEPs) in A) subsarcolemmal mitochondria and B) 36 DEPs in intermyofibrillar 
mitochondria from obese. Heatmaps of differentially expressed proteins in C) su sarcolemmal  and D) intermyofibrillar 
mitochondria of obese relative to lean.
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Figure 4-11. Principal component analysis and heatmaps for differentially expressed 
mitochondrial protein identifications in human skeletal muscle intermyofibrillar 
mitochondria. A) Principal component analysis (PCA) and B) heatmap of 41 
differentially expressed proteins in intermyofibrillar mitochondria; up-regulated (Green) 
and down-regulated (Red) differentially expressed proteins in subsarcolemmal 
mitochondria of obese relative to lean. Columns represent each subject in the study. 
Columns 1 - 17 = obese subjects; columns 18 – 33 = lean controls. 
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Comparing SS-to-IMF protein abundance ratios from overlapping protein identifications in 
SS and IMF mitochondria between lean and obese individuals 
 Based on the findings from this studying showing differences in SS and IMF 
mitochondria of obese, we wanted to investigate if there might be differences in SS-to-IMF 
protein abundance between lean and obese individuals. Therefore, using the 290 overlapping 
mitochondria protein identifications in SS and IMF mitochondria we determined an SS-to-
IMF protein abundance ratio for all 290 mitochondria proteins. We found there was no 
difference in the average normalized spectral abundance for SS-to-IMF protein abundance 
ratios between groups as determined by Unpaired parametric t test (Figure 4-12A). 
Additionally, using 290 overlapping mitochondria protein identifications to compare SS-to-
IMF protein abundance ratios for manually curated protein sets assigned to citric acid cycle, 
electron transport, and ATP synthase showed no differences between groups in (Figure 4-
12B). However, 6 proteins had SS-to-IMF protein abundance ratios that significantly differed 
between lean and obese subjects (Figure 4-13). The SS-to-IMF protein abundance ratios of 
obese relative to lean were expressed as log2 fold change and grouped according to biological 
processes (GO) (Figure 4-13). Among the 6 proteins with significantly different SS-to-
IMF protein abundance ratios in obese, 4 and 2 were up- and down-regulated 
respectively; NU5M, NDUB8, KCRS, PHB, CY1, KAD2. Upon further analysis by 
REACTOME, the top significantly enriched pathways included the citric acid (TCA) cycle 
and respiratory electron transport; (P < 0.01) (Table 4-2). 
 Results from the current study revealed more than a 300% increase in the detected 
abundance of adenylate kinase 2, (KAD2), a highly abundant skeletal muscle 
mitochondrial associated isoform, in SS mitochondria of obese individuals (P = 0.0018) 
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(Appendix A). Also, relevant to the current study was the reorganization and distribution 
of KAD2 within the mitochondrial reticulum between lean and obese individuals. The 
current study revealed a higher abundance of KAD2 in subsarcolemmal mitochondria 
from obese individuals, consequently resulting in the higher SS-to-IMF protein 
abundance ratio in obese relative to lean controls (Figure 4-13). On the contrary, the 
detected abundance of KAD2 from the intermyofibrillar mitochondrial fractions from 
muscle of obese individuals was nearly 22% lower; although statistical significance was 
not achieved (q = 0.108). Similar to KAD2, creatine kinase, mitochondrial 2 
(Sarcomeric), isoform (KCRS), was 56% higher in SS mitochondria of obese, which 
resulted in a higher SS-to-IMF protein abundance ratio in obese; suggests the possibility 
that these skeletal muscle proteins are differentially distributed within the mitochondrial 
reticulum during various physiological conditions, such as obesity (Figure 4-13). 
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Figure 4-12. Average normalized spectral abundance for SS-to-IMF protein abundance 
ratios between lean and obese groups. SS-to-IMF protein abundances ratios for 290 
overlapping mitochondria protein identifications were averaged within each group. Mean 
scaled average NSAF SS-to-IMF protein abundance ratios for manually curated proteins 
sets assigned to the citric acid cycle (TCA), the electron transport chain (complex I – IV), 
and ATP synthase (complex V). Data is presented as mean NSAF SS-to-IMF protein 
abundance ratio ± SEM; Statistical significance determined using Unpaired, parametric t test; 
(P > 0.05)  
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Figure 4-13. Mitochondria proteins with different SS-to-IMF protein abundance ratios 
from obese relative to lean controls are shown. There were 6 among 290 overlapping 
protein identifications in SS and IMF mitochondria with significantly different SS-to-
IMF protein abundance ratios in obese, compared to lean controls. SS-to-IMF protein 
abundance ratios of obese relative to lean expressed as log2 fold change and grouped 
according to biological processes and pathway as revealed by REACTOME analysis; 
NADH dehydrogenase subunit 5, (NU5M), NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 8, (NDUB8), Creatine kinase S-type, mitochondrial, (KCRS), 
Prohibitin, (PHB), Cytochrome c1, heme protein, mitochondrial, (CY1 ), Adenylate 
kinase 2, mitochondrial, (KAD2 ).
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Discussion 
 The primary goal of this work was to investigate the proteome differences in skeletal 
muscle mitochondria between lean and obese individuals. For that purpose, we used label 
free quantitative proteomics along with a comprehensive protein-protein interaction and 
functional pathway analysis approaches. In the present study, we identified 1,449 and 1,016 
proteins in human skeletal muscle subsarcolemmal and intermyofibrillar mitochondria, 
respectively. Among these, 539 and 301 SS and IMF mitochondrial proteins, respectively, 
were detected in >50% of the subjects in the lean and obese groups. Comparing the total 
abundance of normalized spectra from the 539 proteins in SS mitochondria revealed that the 
total abundance of proteins was 2% lower in obese compared to lean controls. We also 
compared the 301 proteins in IMF mitochondria and determined that the total abundance of 
these proteins was 9% lower in the obese subjects when compared to the lean controls. This 
finding is consistent with previous reports of reduced muscle mitochondrial content in obese 
humans (Kurt Hojlund et al., 2008; Kelley et al., 2002; Mogensen et al., 2007; Ritov et 
al., 2005). We showed no difference in the citrate synthase activities, used as an index of 
mitochondrial content (Larsen et al., 2012) as indicated in chapter 3, in either SS or IMF 
mitochondria isolation preparations between lean and obese, suggesting no difference in 
the muscle mitochondria content between groups; this apparent discrepancy between the 
study in chapter 3 and chapter 4 might be explained as follows: citrate synthase activities, 
described in chapter 3, were normalized to total protein (mg) and determined by method 
of Lowry (Lowry et al., 1951), an absorbance assay dependent on peptide bonds. We also 
showed in chapter 2, that the proteins in the final mitochondrial preparations isolated 
from mouse muscle, contain both mitochondrial and non-mitochondrial assigned protein 
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identifications, as determined by mass spectrometry. Therefore using label free 
quantitative mass spectrometry allowed us to identify mitochondria-specific proteins in 
the final SS and IMF mitochondrial preparations for the final analysis performed in this 
study. This, in turn, increased the sensitivity of our measurements, consequently resulting 
in the reported differences in SS and IMF mitochondria between lean and obese 
individuals due to the increased signal to noise ratio. 
 The reduced abundance of SS and IMF mitochondria of obese compared to lean 
controls, lead us to investigate groups of proteins associated with key biological 
processes involved with regulating energy metabolism in skeletal muscle. We manually 
curated sets of proteins using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) Bioinformatics Resources v6.7 (http://david.abcc. ncifcrf.gov) 
(DAVID) and gene ontologies. This allowed us to group together the following sets of 
proteins: (1) the electron transport chain (complex I, II, III, and IV); (2) ATP synthase; 
and (3) citric acid cycle (TCA). We sought to determine if skeletal muscle mitochondria 
from obese subjects have a reduced abundance of proteins associated with citric acid 
cycle, electron transport chain, and ATP synthase, proteins well known for their 
association with the capacity to generate ATP in muscle. 
 Our results revealed that the total abundance of spectra assigned to proteins 
associated with TCA and the electron transport chain, and ATP synthase, were not 
different between lean and obese groups. However, the total abundance of spectra from 
all 539 identified proteins in SS mitochondria was lower by 2% in obese (P <  0.01). To 
reconcile this difference, we sought to compare the total abundance of spectra from other 
proteins not assigned to TCA, electron transport and ATP synthase in SS mitochondria 
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between lean and obese. This analysis revealed that there was significantly lower 
abundance of spectra assigned to proteins not assigned to TCA, electron transport or ATP 
synthase in SS mitochondria of obese versus lean controls (314.4 ± 3.1, n=17 vs. 325.7 ± 
3.0, n=16, ∑NSAF X 1000; P = 0.0136). We analyzed the 539 protein identifications in 
SS mitochondria by REACTOME to reveal that among the 539 protein identifications in 
SS mitochondria, 127 were involved in metabolism of proteins (Pathway ID: R-HSA-
392499) (Appendix A). Among the 127 protein identifications involved in metabolism of 
proteins, 120 were not previously assigned to TCA, electron transport or ATP synthase. 
The total abundance of normalized spectra from these 120 proteins involved in 
metabolism of proteins was significantly lower in SS mitochondria of obese versus lean 
controls as determined by Unpaired parametric t test; (53.8 ± 1.3, n=17 vs. 60.7 ± 1.7, 
n=16, ∑NSAF X 1000; P = 0.0032). This is consistent with previous reports of lower 
rates of protein synthesis in muscle mitochondria from obese subjects (Guillet et al., 2009; 
Tran et al., 2016).  
 On the contrary, the abundance of mitochondria protein identifications assigned to 
TCA along with citrate synthase was increased by over 10% and 54%, respectively, in 
IMF mitochondria of obese subjects when compared to lean controls, providing further 
evidence to support the increased abundance of citrate synthase in muscle mitochondria 
in obese rodent models (Turner et al., 2007). The observation of higher abundance of 
proteins assigned to TCA in parallel with our findings of reduced total abundance of 
proteins assigned to complex I, III and V in IMF mitochondria of obese subjects, suggests 
a difference in protein composition in IMF mitochondria related to the capacity to 
generate ATP, compared to lean controls. Furthermore, this observation of significantly 
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reduced protein abundance of the electron transport chain and ATP synthase in IMF 
mitochondria of obese subjects, suggests a significant reduction in the relative capacity to 
produce ATP, since IMF mitochondria comprise approximately 80% of the total 
mitochondrial volume in skeletal muscle mitochondrial reticulum (Abdul-Ghani et al., 2009; 
Chomentowski, Coen, Radiková, Goodpaster, & Toledo, 2011; Ferreira et al., 2010). We also 
sought to compare the total abundance of spectra from other proteins not assigned to 
TCA, electron transport and ATP synthase in IMF mitochondria between lean and obese 
to determine other pathways based on REACTOME analysis may be contributing to the 
9% lower abundance of total normalized spectra in IMF mitochondria. This analysis 
revealed that there was significantly lower abundance of spectra assigned to proteins not 
assigned to TCA, electron transport or ATP synthase in IMF mitochondria of obese 
versus lean controls (298.0 ± 6.4, n=17 vs. 307.1 ± 20.1, n=16, ∑NSAF X 1000; P = 
0.0136). As expected, REACTOME analysis of the 301 protein identifications in IMF 
mitochondria revealed that 107 protein identifications were involved in the citric acid 
(TCA) cycle and respiratory electron transport (Pathway ID: R-HSA-1428517) (Appendix 
B). 
 Among the 539 mitochondria protein identifications in SS mitochondria, 73 were 
significantly differentially expressed between lean and obese individuals. Among 301 
mitochondria protein identifications in IMF mitochondria, 41 were significantly differentially 
expressed between lean and obese individuals. Bioinformatic interrogation of the 
differentially expressed proteins in SS and IMF mitochondria of obese subjects, revealed the 
following key biological processes by gene ontology related to energy metabolism in muscle: 
oxidation-reduction process; (GO:0055114), cellular respiration; (GO:0045333), small 
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molecule metabolic process; (GO:0044281), carboxylic acid metabolic process; 
(GO:0019752), respiratory electron transport chain; (GO:0022904), ATP metabolic process; 
(GO:0046034), oxidative phosphorylation; (GO:0006119), monocarboxylic acid metabolic 
process; (GO:0032787), mitochondrial electron transport, NADH to ubiquinone; 
(GO:0006120), mitochondrial ATP synthesis coupled electron transport; (GO:0042775), 
phosphorus metabolism; (GO:0006793), and primary metabolism; (GO:0044238) (Appendix 
E and F). 
 REACTOME analysis of the 73 significantly DEP in SS mitochondria, revealed 
categories reflective of key biological processes associated with regulation of energy and 
metabolism in skeletal muscle including the citric acid cycle (TCA), electron transport, ATP 
synthesis, mitochondrial protein import, mitochondrial translation, complex I biogenesis, 
pyruvate metabolism, and metabolism of amino acids. Performing the same analysis on the 
41 DEP in IMF mitochondria, revealed categories reflective of key biological processes 
associated TCA, electron transport, ATP synthesis, complex I biogenesis, and fatty acid 
metabolism. Consequently, the difference in protein composition, as it relates to 
mitochondrial protein import, translation and complex I biogenesis in SS and IMF 
mitochondria between lean and obese, suggest the possibility of dysregulation of distinctive 
key biological processes of protein synthesis (Guillet et al., 2009; Tran et al., 2016), and 
complex I biogenesis (Lefort et al., 2010; Ritov et al., 2010) in muscle of obese subjects. 
Furthermore, our results provide support of previous reports of biochemically distinct 
subpopulations of mitochondria in skeletal muscle (Palmer et al., 1985) with respect to SS 
mitochondria having a protein composition that supports membrane processes, such as 
protein import (Cogswell et al., 1993; D. A. Hood, 2001). Overall, our data show that there 
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are differentially expressed proteins between lean and obese subjects, associated with 
pathways related to mitochondrial translation and metabolism of amino acids localized in SS 
mitochondria and fatty acid metabolism localized in IMF mitochondria. In terms of obesity, 
the pathway and functional annotation analyses reveals that DEPs associated with 
mitochondrial translation, TCA, electron transport, as well as complex I biogenesis, are 
down-regulated in both SS mitochondria and IMF mitochondria of obese subjects. However, 
differentially expressed mitochondrial protein identifications associated with fatty acid 
metabolism are significantly up-regulated in IMF mitochondria of obese subjects compared 
to lean controls as evidence by a 33% average fold change for the 7 differentially expressed 
mitochondria proteins (ACADM, MCAT, ACSF2, ACOT9, AL3A2, ACSL1, CACP) 
assigned to fatty acid metabolism based on REACTOME analysis (Figure 4-9B). These 
results are in line with previous findings, which suggest fatty acid metabolism is up-regulated 
in obese rodent models (Turner et al., 2007).  
 Interestingly, muscle from obese subjects had a higher SS-to-IMF protein abundance 
ratio for creatine kinase S-type, mitochondrial (KCRS), and adenylate kinase 2, 
mitochondrial (KAD2). These results are consistent with previous findings that have shown 
30% increase in enzymatic activity of creatine kinase, which regulates energy metabolism in 
muscle, in obese/overweight women (Hittel, Hathout, Hoffman, & Houmard, 2005). The 
increased enzymatic activity of adenylate kinase in the obese subjects was also reported by 
this same group and was proposed as a representative compensatory glycolytic drift to 
counteract reduced muscle mitochondrial function with the progression of obesity (Hittel et 
al., 2005). The results from this study are in line with these previous findings and further 
show that the higher SS-to-IMF protein abundance ratio of KAD2 and KCRS suggests a 
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redistribution of energy metabolism related to phosphate regulation toward the periphery of 
myocytes in obese individuals (Janssen, Terzic, Wieringa, & Dzeja, 2003). 
 This study also provides evidence suggesting that the reduced abundance of 
proteins in IMF mitochondria, can at least in part, be explained by the reduced abundance 
of proteins assigned to the electron transport chain and ATP synthase. Notably, two key 
catalytic enzymes responsible for the phosphorylation of ADP, ATP synthase subunits 
beta and alpha (ATP5B, ATP5A), which have been previously shown as altered in 
muscle of obese subjects (Højlund et al., 2003; K. Hojlund et al., 2010; Tran et al., 2016) 
were significantly down-regulated in IMF mitochondria of obese subjects in the current 
study. Consequently, these results suggest that the muscle of obese humans having 
significantly reduced capacity to generate ATP may localize in IMF mitochondria. 
Conversely, muscle from obese subjects may have a higher catalytic potential in the 
matrix of IMF mitochondria of obese as evidence by the significantly higher abundance 
of protein identifications assigned to the citric acid cycle, including the mitochondrial 
enzyme marker citrate synthase, which suggests the possibility of increased reactive 
oxygen species with the decreased abundance of subunits from complex I, as previously 
reported (Lefort et al., 2010). 
 Overall, differentially expressed proteins associated with up-regulation of fatty 
acid metabolism were localized in IMF mitochondria, while mitochondrial protein 
identifications associated with the down-regulation of protein synthesis were localized in 
SS mitochondria. Finally, while we showed that the overall abundance of mitochondria 
protein identifications associated with the citric acid cycle and respiratory electron 
transport in SS mitochondria of obese were not different compared to lean controls, we 
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also showed a reduced abundance of identified proteins from ATP synthase or complex 
V, specifically in IMF mitochondria of obese subjects. This significant reduction in 
protein abundance of ATP synthase, a well known protein complex responsible for using 
the proton-motive force in generating ATP in muscle, might explain the significantly 
reduced ATP capacity in skeletal muscle of these subjects (Abdul-Ghani et al., 2009), 
which in turn may result in a progressive decrease in muscle mitochondrial function, 
exacerbating the state of obesity 
 Although previous studies have reported lower muscle mitochondrial content as 
determined by the activity or abundance of the mitochondrial enzyme marker citrate synthase 
(Kelley et al., 2002; Lefort et al., 2010; Mogensen et al., 2007; Ritov et al., 2010; Simoneau 
& Kelley, 1997), our findings suggest the contrary. In fact, normalized spectral abundance of 
the enzyme marker was not different in SS mitochondria of obese and nearly 54% higher in 
IMF mitochondria of obese subjects; FDR ≤ 0.05; (p = 0.054) (Appendix B). The possible 
increase in abundance of citrate synthase in the IMF mitochondria of obese subjects 
compared to lean controls, is in concert with the higher coexpression of up-regulated 
mitochondrial proteins associated with the citric acid cycle and specifically the elements of 
the electron transport chain (succinate dehydrogenase: complex II) responsible for the 
oxidation of reduced flavin adenine dinucleotide (FADH2) in IMF mitochondria of the obese, 
and agrees with previously reported up-regulation of citrate synthase in skeletal muscle of 
obese animal models (Benton et al., 2008; Jain et al., 2014). It is also worth noting that the 
abundance of proteins associated with complex II was significantly higher in IMF 
mitochondria of obese compared to lean controls. Other groups have reported differences in 
complex II in muscle mitochondria of obese subjects related to fiber type switching (Tanner 
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et al., 2002). Since IMF mitochondria are normally associated with higher activity of 
oxidative phosphorylation (Ferreira et al., 2010) and we found that the IMF mitochondria of 
obese subjects have a reduced abundance of mitochondria proteins assigned to the electron 
transport chain, it is warranted to consider the following: muscle IMF mitochondria of obese 
may have the ability to up-regulate succinate dehydrogenase or complex II, to accept electron 
transfer of NADH: ubiquinone oxidoreductase (i.e. complex I), which may be in part, due to 
nutrient overload observed in the obese (Iossa et al., 2004). This in turn could result in a 
reduced capacity for reactive oxygen species generation originating at the site of complex I 
(Pryde & Hirst, 2011). 
 In summary, this study shows the total abundance of normalized spectra of 
mitochondria proteins was reduced by a modest 2% in SS, but to a greater degree of 9% 
in IMF mitochondria of obese compared to lean controls. The differences in protein 
composition of SS and IMF mitochondria between lean and obese subjects confirmed the 
biochemically distinct nature of the two subpopulations with respect to function (i.e. 
mitochondrial protein import localized in SS and fatty acid metabolism in IMF 
mitochondria). Furthermore, this research presents novel findings in obesity, with respect 
to regulating energy metabolism in skeletal muscle, as well as reveals possible 
mechanisms to explain the reduced capacity of ATP in skeletal muscle of the obese. 
Overall, these findings show that obesity is associated with differences in protein 
composition in both SS and IMF mitochondria of obese related to key biological 
processes responsible for regulating energy metabolism in skeletal muscle.
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CHAPTER 5: CONCLUSION 
 In this dissertation, we set out to reveal the functional and proteome differences in 
skeletal muscle mitochondria between lean and obese humans. Using oxygen electrode 
polarography and label free quantitative mass spectrometry, we were able to test our 
specific hypotheses, and discover novel findings in obesity. We also were able to 
investigate specifically the differences in protein composition and function of two 
subpopulations of skeletal muscle mitochondria located in the periphery, subsarcolemmal 
(SS) mitochondria, and in the interior of the cell, intermyofibrillar (IMF) mitochondria, 
as well as investigate any differences in protein composition and function associated with 
obesity. Lastly, we were able to demonstrate a significant difference in protein 
compositions in both the SS and IMF mitochondria, between lean and obese subjects, 
associated with regulating energy metabolism in skeletal muscle. 
 Our first study investigated the function of skeletal muscle mitochondria in mouse 
muscle, when using a protease to isolate mitochondria from skeletal muscle. Using a 
protease, such as the bacterial protease nagarse, is a common technique employed in 
preparations of mitochondria from tough tissues such as skeletal muscle (Dow, 1967; 
Idell-Wenger, Grotyohann, & Neely, 1982; Palmer, Tandler, & Hoppel, 1977; Thakar & 
Ashmore, 1975). We showed that using a protease during isolation preparations of 
skeletal muscle mitochondria reduces the abundance of proteins, by nearly 25%, in the 
final mitochondrial suspension; the majority of contaminating proteins that were reduced 
as a result of the protease treatment, were proteins not assigned to mitochondria. Overall, 
the data indicated that skeletal muscle mitochondria preparations isolated using protease 
effectively removes a significant abundance of non-mitochondrial proteins and 
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substantially increased	mitochondrial catalytic potential and energetic coupling. This 
study was important to our overall work to demonstrate, like others previously (Palmer et 
al., 1977; Palmer, Tandler, & Hoppel, 1985), preparations of skeletal muscle 
mitochondria exposed to protease, results in mitochondria isolates exhibiting high 
function, but more importantly, demonstrated a confounding difference between 
preparations of isolated SS mitochondria treated and not treated with nagarse. Since 
future studies in this dissertation involved the study of two subpopulations of skeletal 
muscle mitochondria, SS and IMF mitochondria, we concluded that we could not directly 
compare functional and proteome differences between SS and IMF mitochondria, when 
one subpopulation of skeletal muscle mitochondria is isolated with protease. Aware of 
this confounding effect of using nagarse to isolate mitochondria from skeletal muscle, the 
studies detailed in chapters 3 and 4 emphasized differences in SS mitochondria between 
lean and obese subjects, independently and separately, from the compared differences in 
IMF mitochondria between lean and obese groups. 
 In the second study, we investigated the differences in skeletal muscle 
mitochondrial function between lean (BMI < 25 kg/m2; 37 ± 3 yrs; n = 10) and obese 
(BMI > 30 kg/m2; 35 ± 3 yrs; n = 11) individuals in response to amino acids infusion. 
Amino acids are well known for stimulating mitochondrial ATP production in SS 
mitochondria of healthy lean subjects (Tatpati et al., 2010). In chapters 3 and 4 of this 
dissertation, we successfully isolated two subpopulations of skeletal muscle 
mitochondria, SS and IMF mitochondria, using previously established techniques (Kras 
et al., 2016; Palmer et al., 1977, 1985). Subsequently, we demonstrated that a four-hour 
infusion of amino acids (AA) enhanced the capacity for respiration and ATP production 
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of muscle SS, but not IMF, mitochondria in lean individuals in parallel with increased 
uncoupled respiration. However, neither of these parameters increased in SS or IMF 
mitochondria in obese individuals. We also established that treating isolated SS 
mitochondria with amino acids elicits a similar response, which was in agreement to what 
we observed in the human isolated SS mitochondria in vivo (i.e. increased in state 3 Jo 
oxygen consumption and ATP production). Our in-vitro assays of isolated SS 
mitochondria from mouse muscle treated with amino acids in chapter 3 revealed a 
significant increase in the capacity of SS mitochondria to generate ATP in response to 
amino acids treatment.  
 The second study of this dissertation also described that amino acids infusion 
stimulated proton leak (state 2 Jo) of SS mitochondria from lean subjects, where amino 
acids did not affect the proton leak rate of SS mitochondria of the obese subjects. Higher 
rates of proton leak may suggest the activation of uncoupling proteins (Crescenzo et al., 
2014), a well-defined proton leak pathway (Crescenzo et al., 2014; Lambert & Brand, 
2004). Thus, these results show reduced activation of proton leak pathways in SS 
mitochondria from obese humans in the presence of increased plasma amino acid 
concentrations.  
  We concluded from the second study that AA infusion stimulated skeletal muscle 
ATP production in the lean but not the obese. The data further suggest mitochondria from 
obese may be overstimulated at rest and AA treatment improves ADP/O coupling. In 
turn, there may be physiological mechanisms which allow skeletal muscle mitochondria 
to adjust oxygen consumption rates in subsarcolemmal mitochondria during states of 
increased availability of amino acids, which may not be present in the intermyofibrillar 
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mitochondria populations of both lean and obese individuals. Moreover, the uncoupling 
affect, or higher respiratory control ratios, observed in subsarcolemmal mitochondria 
after AA further supports that mitochondria in the periphery of myocytes, which seem 
particularly affected by obesity, may be more adept to control proton flux, while 
simultaneously, maintaining ATP production capacity. Future studies are needed to 
investigate the exact mechanisms by which AA stimulates ATP production through 
complex-I and complex-II enzyme pathways, and results in oxidative phosphorylation 
uncoupling of subsarcolemmal mitochondria in lean but not obese individuals and the 
potential effects of chronic amino acid supplementation to treat obesity. 
 In chapter 4, we determined differences in proteomes of SS and IMF 
mitochondria between lean and obese individuals. The overall findings suggested that 
obesity is associated with changes in protein composition within the skeletal muscle 
mitochondria reticulum, which results in a reduced capacity of ATP production. We 
showed a reduced total abundance of normalized spectra in both SS and IMF 
mitochondria of obese relative to lean controls. We further demonstrated that among the 
539 and 301 mitochondria protein identifications in SS and IMF mitochondria, 
respectively, 73 and 41 were differentially expressed in either the SS or IMF 
mitochondria of obese subjects and were associated with biological processes that 
regulate electron transport chain (P<0.0001), citric acid cycle (P<0.0001), oxidative 
phosphorylation (P<0.001), branched-chain amino acid degradation, (P<0.0001), and 
fatty acid degradation (P<0.001). We provided evidence that supports the biochemical 
distinct nature of SS and IMF mitochondria. We also showed differential abundance and 
redistribution of proteins involved in citric acid cycle, electron transport and phosphate 
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shuttling as evidenced by the higher SS-to-IMF protein abundance ratios for KAD2, 
KCRS, CY1, along with prohibitin (PHB), a protein which may play a role in regulating 
mitochondrial respiration activity. Work with respect to Chapter 4 is summarized in 
Figure 5-1, showing that obesity is associated with an overall differential abundance of 
mitochondrial proteins, evident particularly in the IMF subpopulation in skeletal muscle.  
Specifically, IMF mitochondria have reduced expression of complex I, complex III and 
complex V proteins, but increased expression of proteins related to the TCA cycle.  
The overall findings of this research work in lean versus obese humans are important 
with respect to: (1) understanding physiological changes associated with the 
dysregulation of energy metabolism in skeletal muscle of obese subjects; (2) revealing 
novel findings in obesity with respect to the distribution of protein composition in 
myocytes related to regulating energy metabolism; and (3) focusing future studies on 
assessing ways to improve the capacity of ATP production in skeletal muscle 
mitochondria of the obese, which predictably would result in a higher daily expenditure 
of energy, whereby lowering the risks associated with obesity in humans. These results 
support and extend the concept that obesity is associated with skeletal muscle 
mitochondria dysfunction and disruptions in the regulation of energy metabolism. These 
studies pave the way for future investigations that elucidate the mechanisms responsible 
for the reduced response to amino acid stimulation in SS mitochondria from obese 
individuals, specifically related to respiration not coupled to generating ATP (i.e. 
uncoupled respiration). These studies also provide us with a better understanding of the 
mitochondrial protein composition in SS and IMF mitochondria in healthy lean and 
relatively healthy obese humans. Future investigations are needed to identify the 
	 158 
mechanisms responsible for the reduced abundance of proteins involved in protein import 
and protein translation in the periphery of muscle cells, as well as the reduced abundance 
of proteins associated with the electron transport chain (i.e. complex I and complex III) 
and ATP synthase (complex V) in the interior of muscle cells during obesity. 
Understanding the protein compositional changes in skeletal muscle mitochondria in 
obesity is a crucial functional interface between mechanisms involved in regulating 
whole-body energy expenditure, and improving the regulation of body weight.
	 159 
 
Figure 5-1. Model depicting protein abundance in human skeletal muscle mitochondria of 
lean and obese individuals. Citrate synthase (CS); Tricarboxylic acid (TCA) cycle; 
NADH: ubiquinone oxidoreductase (complex I); Succinate-coenzyme Q reductase 
(complex II); Cytochrome c – oxidoreductase (complex III); cytochrome c oxidase 
(complex IV); and ATP synthase (complex V). Increased catalytic potential in IMF 
mitochondria of obese subjects, as it is evident by the higher abundance of proteins 
associated with the TCA cycle. A lower abundance of proteins involved in electron 
transport and ATP synthase in IMF Mitochondria of obese subjects suggests an overall 
reduced capacity of ATP generation in muscle of obese subjects.
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APPENDIX B 
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APPENDIX E 
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APPENDIX G 
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Features of isolated skeletal muscle mitochondrial preparations 
 
  The preparation of skeletal muscle from either SS mitochondria or IMF 
mitochondria between lean and obese (n = 3), measured in triplicate, provided similar yields 
as determined by Unpaired t tests; SS mitochondria, lean versus obese (38±5% versus 
32±12%; P>0.05); IMF mitochondria, lean versus obese (43±13% versus 33± 1%; P>0.05)  
The fractional yield of isolated subsarcolemmal and intermyofibrillar mitochondria 
preparations from muscle of lean and obese individuals. The present preparation of SS 
and IMF mitochondria from muscle of lean (n=3) and obese (n=3); A) SS mitochondria 
fractional yield from lean and obese; 41.5 ± 4.9% versus 31.1 ± 6.1%; P > 0.05; B) IMF 
mitochondria fractional yield from lean and obese; 43.3 ± 6.0% versus 35.6 ± 3.3%; P > 
0.05; assayed as citrate synthase activity in the final preparation of SS and IMF 
mitochondria fractions relative to the total citrate synthase activity recovered following 
whole muscle homogenization; Data presented are ±SEM; significance determined by 
parametric, Unpaired t test; P < 0.05.
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